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Seasonal influenza is one of the most common infectious diseases with great disease burden. Public 
health professionals have given many afford to estimate the accurate the disease burden and monitor 
temporal trends of seasonal influenza. However current influenza surveillance system in South Korea 
could not provide full functions on disease burden estimation and temporal trends monitoring. There is 
a need for supporting structure to make robust surveillance.  
In aim 1, we aimed to estimate the burden of influenza and its related disease based on billing 
information from the national health insurance service – national sample cohort. We found that rural 
area of South Korea has more disease burden compared to the urban area and age under 5 had the 
highest burden of influenza infection.  
In aim 2, we assess the timeliness of influenza epidemiological information from billing system 
compared to current sentinel surveillance as temporal trends monitoring. We did not observe any delays 
of influenza out-patients activity compared to current sentinel surveillance in peak time and cross-
correlation value comparison. We could not fully apply aberration time comparison since aberration 
signals highly depended on model sensitivity and specificity and model selection process itself. 
In aim 3, we were able to perform influenza temporal trends association analysis by subpopulations. 
The Seoul Capital Area showed the early signs of influenza activity in peak and cross-correlation time 
comparison. Age 6 to 15 showed the earlier sign of influenza activity while age over 65 showed the later 
sing of influenza activity.  
We were able to estimate the burden of influenza with different case definitions and provided 
stratified disease burden as WHO guided. We did not see any delays of influenza out-patient activity 
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from billing system compared to the current sentinel surveillance. Moreover, we observed potential 
temporal associations of influenza activity by different subpopulations.  
A surveillance system based on solely billing information cannot be perfect by itself. Instead, 
combinations of surveillance structures with a different source for disease information can be called a 
robust surveillance system. The surveillance system should have different arrangements with the 
various data source to make concordance of observation. 
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Background of Influenza 
The names of influenza  
The origin of term influenza is from Italian ‘influentia’ meaning the influence of stars reflects the 
seasonal trends of disease in a temperate region1. As it is described from its name, influenza usually 
shows its seasonal patterns in a temperate region. Recent studies find out that influenza also shows 
different patterns based on location, climate, and altitude2–4. Nowadays, it is generally considered that 
it shows single or double peaks annual patterns in a temperate region and irregular patterns in a tropical 
climate. In a single peak pattern, it usually started its highest activity at the end of the winter and 
resolved its activity at the beginning of the spring. In the double-peak pattern, it usually showed an 
earlier peak in the begging of winter, slightly resolved then, showed another peak at the end of the 
winter. Those double peak patterns can be described due to mutation of unstable influenza strains in 
the middle of the season.  
Influenza viruses, which are causing influenza infection, are classified in four different families: 
influenza virus A, B, C, and D5–8. Influenza A and B are normally considered as a source of the 
symptomatic human infections. Influenza is named by their virus type, geographical origin, strain 
number, year of isolation and virus subtypes (mostly for Influenza A only)5. Influenza A is one of the 
common types of influenza circulating as a human pathogen, caused human influenza pandemics in 
history. One of the most famous influenza A subtype is H1N1 which caused 1919 Spanish flu and also 
2009 Swine Flu pandemic7,9. H3N2 is also one of the common subtypes which is circulating during the 
high activity season. Influenza B is not classified as virologic serotypes like influenza A but addressed in 
two different lineages, Yamagata and Victoria. Since Influenza A and B are the most dominant strains 
circulating high activity season, those influenza types and subtypes have been included the influenza 
vaccine to reduce the influenza burden10. However, not all influenza types and subtypes are susceptible 
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to human. Most of the known influenza subtypes are only infective to animals; humans are only 
susceptible to a few subtypes. Sometimes those cross-species – zoonotic influenza infections between 
animals and human can be a point for mutation of influenza. The mutated influenza strains from cross-
species infection could be a potential cause of the pandemic outbreak; public health professionals also 
need to focus on influenza activity in animals also. 
Every year dominant circulating influenzas are changed. The World Health Organization announced 
the most suspected circulating influenza types each year before the influenza season starts at north and 
south hemisphere11. Traditionally, the trivalent vaccine has H1N1, H3N2, and one of Victoria or 
Yamagata lineages based on prediction, and the quadrivalent vaccine has H1N1, H3N2 and both of 
Yamagata and Vitoria. For season 2018-2019, A/Michigan/45/2015 (H1N1)pdm09-like virus, 
A/Singapore/INFIMH-16-0019/2016 A(H3N2)-like virus, and B/Colorado/06/2017-like (Victoria lineage) 
virus (updated) were in trivalent vaccines, and  B/Phuket/3073/2013-like (Yamagata lineage) were 
added on top of trivalent vaccines as quadrivalent12. For season 2019-2020, Influenza 
A/Michigan/45/2015 (H1N1)pdm09-like virus, Influenza A/Singapore/INFIMH-16-0019/2016 (H3N2)-like 
virus, and Influenza B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage) are projected for the 
trivalent vaccines, and Influenza B/Phuket/3073/2013-like virus (B/Yamagata/16/88 lineage) will be 
added for the quadrivalent vaccine13.  
Epidemiology of Influenza 
One-third of influenza infections are asymptomatic, but common clinical features of influenza are 
described as acute onset of fever, rhinorrhea, cough and sore throat14. There are also other signs or 
symptoms of influenza such as nasal congestion, sneezing, hoarseness, muscle pains or fatigue15. The 
duration of influenza symptom usually is 3-5 days but sometimes lasted up to 9 days. Total symptoms of 
influenza typically started on day 1 after inoculation and showed the highest activity at day 3. The peak 
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of body symptoms was observed earlier, at day 2, than total symptoms, and it regressed earlier than 
other topical symptoms such as respiratory or nasal symptoms16. 
Disease burden  
Disease burden of influenza is extensive. Until 2017, the World Health Organization stated the total 
number of annual death due to influenza was 250,000–500,00017, and a recent study said the number of 
death due to influenza ranged from 148,000 to 249,00018. In 2018, a new study with an advanced 
method with current data re-estimated the disease burden and concluded that previous estimation was 
outdated and underestimated the disease burden19. In a new estimation, the number of deaths due to 
influenza is 300,000-650,000, and the highest mortality was observed in Sub-Saharan African and East 
Asia regions. Age over 75 showed 10 times higher estimated mortality compared to the general 
population, and approximately 17% of deaths were observed at age under 5. The influenza 2017-2018 
season was predominated by influenza B/Yamagata lineage, showed almost same peak and the onset of 
its season compared the last year. But influenza prolonged longer compared to the last year in Europe 
and North America20,21. 
Disease burden in South Korea 
Excess mortality due to influenza in South Korea has estimated 2,900 deaths per year, and the 
burden is highly concentrated in age over 6522. And disease burden is varied by time and dominant 
strains. (H3N2 subtype is highly lethal to older age group). The annual cumulative laboratory-confirmed 
influenza out-patient cases were 242.8 cases per 100,000 adults, and the laboratory-confirmed influenza 
admitted-cases were 57.9 cases per 100,000 adults in the 2013-2014 season23. For the socioeconomic 
burden, total medical cost due to influenza out-patient activity was approximately 4.1 million USD in 
season 2007-2009, and 214.7 USD million in pandemic season, season 2009-2010. The overall 
socioeconomic cost due to influenza is increasing over time from 42 million USD to 125 million USD24. 
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However, there has been a debate on estimating the disease burden of influenza due to difficulties 
in estimating complications and secondary infections25. Influenza can escalate other chronic conditions 
such as COPD (Chronic-obstruction Pulmonary Disease), asthma, and congestive heart failure. And it is 
also known as a risk factor for cerebrovascular accident, myocardial infarction, and fetal loss during 
pregnancy. Moreover, influenza also increased the likelihood of coinfection such as pneumonia and 
acute lower respiratory infection which also can be occurred without influenza infection.  
Risk Factor of Influenza infections 
Risk factors for influenza can be used for the vaccination strategy26–30. In high-income countries, 
children age under 6 and older adults are generally considered as a high-risk group based on age. Also, 
individuals with chronic medical conditions, respiratory disease, such as asthma or chronic obstruction 
pulmonary disease, cardiovascular disease (coronary artery disease), endocrine disease (diabetes), 
hepatic disease (liver cirrhosis), renal disease (chronic renal failure) and neurological/neuromuscular 
disease (Parkinson disease), are considered high risk groups in influenza infection. Lastly, morbid obesity 
and physical handicaps which reduced respiration functions and individuals with immunosuppressed 
status due to hematological conditions or HIV infections are also considered target individuals for 
influenza vaccination. 
However, those risk factors are not universal risk factors. A recent study found that those risk 
factors may act differently depends on the end outcome (common influenza infection, severe influenza 
infection/influenza mortality) and location (high-income countries, or low- and middle- income 
countries)31. For example, age under 5 has a lower risk compared to the older children (age 6-19) having 
a severe outcome, intensive care and/or death, in high-income counties. But those young children in 
low- and middle-income countries more like to have a severe outcome compared to the older children. 
Pregnant women or people lived with HIV/AIDS also have increased the risk of severe outcome in low- 
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and middle-income countries while the individuals in high-income countries do not. Therefore, it is 
imperative to identify the population with a high burden of influenza or high risk by different case 
definitions in different countries. 
Public Health Surveillance  
Definition of surveillance  
Based on definitions of surveillance, there are three significant points in surveillance; a) continuous 
and systematic collection of data, b) analysis and interpretation of disease with results dissemination, 
and c) assessment of the distribution of results with actions implementation. The World Health 
Organization said, “public health surveillance is the continuous, systematic collection, analysis, and 
interpretation of health-related data needed for the planning, implementation, and evaluation of public 
health practice32.” The dictionary of epidemiology by Porta also has the same meaning of surveillance in 
a different language. “Systematic and continuous collection, analysis, and interpretation of data, closely 
integrated with the timely and coherent dissemination of the results and assessment to those who have 
the right to know so that action can be taken33.” However, those three key points of public health 
surveillance have not fully implemented in national and global surveillance; there is a great need of 
revising the guidelines and promoting the importance of collections, dissemination, and implementation 
in public health surveillance34.  
Guidelines for surveillance and disease burden estimation of influenza 
After the recent event of global pandemic influenza and discussions of revisions of the guidelines, 
the World Health Organization released two publications for influenza surveillance and disease burden 
estimation. Those papers emphases the importance of influenza surveillance and disease burden 
estimation and presented out practical points in actual implementations35,36. The key features are 
described as the use of age stratification, the use of sentinel validations with representativeness, case 
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definitions for influenza-like-illness and severe acute respiratory illness, defining denominator (in 
disease burden estimation), and developing seasonal/alert thresholds (in surveillance). 
Review of Influenza Surveillance System in South Korea 
History of influenza surveillance system  
The history of influenza surveillance system in South Korea started in 199737. Even though there was 
an international influenza network by the World Health Organization in South Korea, there was no 
stable national influenza surveillance system until 1997. The influenza surveillance was established in 
1997 with 71 doctors in 16 different geographical subdivisions. But the actual participation to influenza 
surveillance was not adequate. Only 70% of the participants reported weekly influenza-like-illness 
patient at least once, and average weekly report participation was between 30% to 50%. On the other 
hands, Korea also established virology surveillance to identify the types and subtypes of influenza to 
calculate the percentage of positive isolations from the specimens.  
In 2000, Korean Influenza Surveillance Scheme (KISS) was launched as a revised influenza 
surveillance network38. It had 239 government clinics (described as public health clinics) and 383 private 
clinics for influenza-like-illness sentinel surveillance and 163 government and 108 private clinics for 
specimen sites for laboratory surveillance. In this revision, they designed to match the number of 
participated clinics with population distribution. Even though they aimed to cover 100,000 individuals 
per one private clinic, it ended with 123,000 individuals. However, the proportion of influenza-like-
illness did not match in government and private clinics, and sometimes government clinics reported 0 
cases of influenza-like-illness. Even at the time of the pandemic influenza season at the year 2009 – 
2010, sentinel influenza surveillance yielded almost the same epidemiological curve compared to the 
previous season39. Then there was another need to a reformation of the influenza surveillance system. 
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Reformation of influenza surveillance system 39–41. 
After historic pandemic influenza 2009, there was another discussion on reformation of the 
influenza surveillance from the government and academia. As it was noted above, sentinel surveillance 
did not catch the high pandemic activity in influenza-like-illness and governments clinic and it showed 0 
cases occasionally. In the year 2013, there was a second revision of influenza surveillance. Instead of 
more than 800 governments and private clinics, they selected only 200 clinics, 70 internal medicine, 30 
family medicine, and 100 pediatrics, based on the recommendation from the regional doctor’s 
association42. The revised surveillance provides four different regional activities based on sentinel sites 
(Seoul-Gangwon, Chungcheong, Jeolla and Kyungsang), and also provides influenza activity by age group 
stratification (age 0 to 6, 7-18, 19-49, 50-64, and over 65).  
Limitations of current surveillance system 
Even though there were two significant revisions of influenza surveillance in South Korea, there are 
few more aspects that need to be discussed to provide more detailed information on the influenza 
activity43. First, there is a lack of the population representativeness in the sentinel sites. Current 200 
sentinel sites are based on recommendation from regional doctors’ association (convenient selection), 
they did not consider any representativeness in the selection process. Moreover, there are 226 minor 
geographical and political subdivisions in Korea, which is equivalent of county level in the US, but 
current surveillance system has only 200 sentinels, which means some subdivisions did not have 
sentinels in their location. Second, there is a lack of geographical stratification. Even though the current 
sentinel surveillance system provides 4 different geographical regions, those are more like cultural / 
regional classification, not policy implementable stratification. One of the main points of the surveillance 
is providing public health interventions based on the results. The second largest in Korea, after the 
national level, is 17 different geographical subdivisions. Therefore, there is a need to provide influenza 
activity based on those 17 subdivisions. Third, influenza-likeliness may not display disease intensity 
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correctly in a specific age group. Because the population at risk cannot be defined in the sentinel 
surveillance, proportion (percentage) of influenza-like-illness compared to the total number of out-
patient visit normally used as a metric of disease intensity. However, those proportions may 
underestimate in the older age group. They do have more medical visits compare to other age groups 
due to their chronic medical conditions, using a total number of medical visits increase the number of 
denominators in a proportion calculation which may result decrease the proportion of influenza-like-
illness in that age group. Older age is identified as a risk group for influenza infection, more precise 
monitoring on influenza activity with disease intensity is required. Lastly, there is no information on 
severe cases of influenza. In a recent guideline from the WHO35,36, it stated that countries need to focus 
on not only influenza out-patients (influenza-like-illness), but also severe influenza cases (severe acute 
respiratory illness). The only available case definition in influenza surveillance in South Korea is 
influenza-like-illness in outpatient; no other case definitions with severe cases are not available.  
Study proposal  
We propose to develop an innovative seasonal influenza surveillance system based on disease 
diagnosis codes in the billing information from National Health Insurance Service-National Sample 
Cohort (NHIS-NSC). We aim to understand the population distribution of the burden of seasonal 
influenza in South Korea, validate the timeliness of new approach compared to the current system, and 
identify the temporal association of influenza activity. The different disease diagnosed codes in the 
billing information will be able to estimate various range of seasonal influenza burden from influenza 
out-patients visits to admitted other acute lower respiratory infections. Timeliness validation approach 
by three different timeliness comparison will ensure the use of a new approach to temporal trends 
monitoring. Lastly, temporal associations by different geographical subdivisions and age-groups will 
provide early signals of the beginning of seasonal activity of influenza in South Korea.  
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Specific aim 1 
To estimate the case burden of seasonal influenza and acute respiratory infections in South Korea by 
applying different case definitions in the National Health Insurance Service. We will use influenza and its 
related disease diagnosed codes in NHIS-NSC to estimate the burden of seasonal influenza by different 
geographical subdivisions and age groups.  
Hypotheses: There will be a no difference in the incidence of seasonal influenza by age, income level 
and geographical location in South Korea year 2007 to 2013.   
Specific aim 2 
To assess the timeliness of the proposed approach compared to the current sentinel system in 
temporal trends monitoring by timeliness validation methods. We will apply peak time comparison, 
aberration detection time comparisons and maximum cross-correlation values to quantify the time 
difference. Hence, we can examine the timeliness of new approach and display the potential possibility 
of use of NHIS-NSC in temporal trends monitoring. 
Hypothesis: There will be no time difference between proposed approach end current sentinel in 
South Korea year 2010 to 2013. 
Specific aim 3 
To evaluate the temporal association of seasonal influenza activity by different geographical levels 
and age groups in South Korea. We estimate the peak time, aberration detection time and maximum 
cross-correlation values by different geographical subdivisions and age-groups. Then compare the time 
difference between subpopulations and the national activity. 
Hypothesis: There will be no time difference of seasonal influenza activity in peak time, aberration 
time and maximum cross-correlation value comparisons in South Korea year 2010 to 2013. 
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Conceptual framework  
 
Figure 1-1. The Conceptual Framework of current influenza sentinel surveillance and proposed surveillance 
 
Our conceptual framework displays the overall flow of the aims of the proposal. We aim to 1). 
Estimate the burden of influenza and influenza-like-illness related diseases in Korea using the National 
Health Insurance Service (National Sample Cohort) by applying different combinations of disease 
classification codes; 2) Assess the timeliness of new approach to current source by comparing peak 
comparison, aberration detection comparison, and correlation analysis; and 3). Identify the temporal 
associations of seasonal influenza activity by different age-groups and geographical subdivisions through 
timeliness comparison methods  
Organization of the Dissertation 
This dissertation is organized into five chapters: Chapter 1 provides background of influenza and 
surveillance and limitations of the current influenza surveillance in South Korea; Chapter 2 covers the 
estimates of influenza case burden using different case definitions by time, geographical subdivision, 
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and age group; Chapter 3 brings the timeliness of new approach compared to the current sentinel 
system in a view of temporal trends monitoring; Chapter 4 explores the temporal association between 
different geographical subdivisions and age groups; and Chapter 5 offers executive summaries of each 
findings, a discussion of the implications of findings into public health practice, and future directions of 
influenza surveillance from findings.  
Dataset Description: National Health Insurance Service National Sample Cohort. 
The origin of the National Health Insurance Service–National Sample Cohort (NHIS-NSC)  
National Health Insurance Services in South Korea developed a population-based cohort, the 
National Health Insurance Service–National Sample Cohort (NHIS-NSC) 44,45. The primary purpose of 
establishing the cohort was to provide representative information about citizen’s use of health 
insurance, medical expenditures and medical examinations for public health research and health policy 
development.  
South Korea provides universal, national wide, electric, mandatory health insurance since 2000. The 
results have been the development of a massive information about medical utilization with great 
interest and availability for researchers. NHIS first provided a population database called ‘National 
Health Information Database (NHID)’ containing individual information, demographics and medical 
treatment data, and eligible individual’s insurance status. Due to its large size and lack of confidentiality 
regarding individual information, NHIS decided to provide a national representative sample database 
with considerable volume size with a de-identification.  
Total 1,025,340 individuals were randomly selected from 2.2% of the total eligible Korean 
population in 2002. A systematic stratified random sampling process was performed at 1476 strata with 
age group, sex, eligibility status and income level using proportional allocation by individual’s total 
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annual medical expenditures as a target variable. Till 2013, NHIS followed up the original sample cohort 
with censoring and adding cohort. Individuals who are disqualifying health insurance eligible were 
eliminated from sample cohort and newborn babies were added annually at 84 different strata by their 
sex and guardian’s income level. 
Available information from the National Health Insurance Service–National Sample 
Cohort  
The cohort has four different types of databases. The first database is about individuals’ insurance 
eligibility; the second database is about medical treatment records; the third database is about care 
provider institution information and the fourth database is about general medical/health examination. 
In this proposal, we mainly focus on one of the sub-databases of medical treatment database: details of 
diseases and prescriptions for surveillance method and insurance eligibility database for epidemiological 
risk profiles. The medical treatment database has four sub-databases; electric medical treatment bills, 
bill details, details of diseases and details of prescriptions. The insurance eligibility database has 14 
different variables; gender, residential area, type of health insurance, a level of income, type and degree 
of disability register, birth and death, and others. 
Characteristics of the National Health Insurance Service–National Sample Cohort 
The National Health Insurance Service–National Sample Cohort (NHIS-NSC) has two distinctive 
characteristics; a representative population-based cohort data and large scale, extensive and stable 
follow up from national wide health insurance. Representativeness is a major strength due to its 
application to public health research, health policy development, and public health surveillance. The 
large sample size with ongoing follow-up process provides enough statistical power to analyze the 
complex models and overcomes the limitation of cross-sectional data. 
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However, the literature of cohort profile on NHIS-NSC stated that there are several limitations on 
NHIS-NSC database. First, information on rare diseases may not be sufficient. NHIS strongly suggest 
conducting pre-evaluation of a sample size to investigate the rare disease. However seasonal influenza is 
a common disease, not a rare disease, we expected that we have enough statistical power to conduct 
surveillance. Second, disease classification code in sub-data: details of diseases may not actual disease 
status which participant individuals have. The code was created to claim health insurance benefits and 
services from health care providers. Therefore, we will use different event-based case definitions to 
estimate seasonal influenza infection.  
Dataset acquiring process and logistics  
To access NHIS-NSC data, we submitted a research proposal and a confirmation of Institutional 
Review Board (IRB) review exemption documents from Public Institutional Bioethics Committee 
(Institutional Review Board) designated by the Ministry of Health and Welfare (South Korea) and Johns 
Hopkins Bloomberg School of Public Health Academic Affairs to the Review Research Committee of 
NHIS. By 2015, the NHIS-NSC database contains 156 data files consisting of 13 files for participants' 
insurance eligibility (1 file), medical treatments (10 files), medical care institutions (1 file) and health 
examination (1 file). - 12-year cohort between 2002 and 2013. The total size of the cohort file is about 
211 gigabytes, and there are 299 million cases of 2002 to 2013 years.  
After permission from NHIS, we were only able to access the data from the designated location in 
South Korea. We downloaded the data of different subunits and separated database, then merged into 
the final dataset format by including and excluding criteria. After the merging process, the intermediate 
dataset was reviewed by NHIS, and we could download the de-identified population-level dataset to the 
personal computer. We only used merged data in the analysis; however, we ensured that any data 
related to the dissertation is stored on a secure, double password-protected laptop. 
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Chapter 2 : Burden of seasonal influenza and its associated respiratory 





Objective To estimate the burden of seasonal influenza in South Korea and identify the sub-population 
with the highest burden by age and geographical stratification.  
Participants Randomly stratified-selected 1,084,673 individuals from the entire South Korean population. 
Followed from the 36th week of 2006 to 35th week of 2013.  
Methods We applied 3 different case definitions based on ICD 10 to the national health insurance billing 
information to estimate the burden of influenza-related medical activity. We also stratified individuals 
based on age categories and geographical region.  
Results The annual incidence rate of ‘influenza outpatient’ were 6.8, 7.7, 8.6, 60.1, 4.9, 9.5, and 3.6 cases 
per 1000 individuals from 2006 season to 2012 season respectively. The annual incidence rate of 
admission due to ‘pneumonia and influenza’ and ‘severe acute respiratory illness (SARI)’ were 4.3, 4.1, 
4.2, 6.1, 6.7, 8.5, and 6.8 and 5.2,5.2, 5.5, 7.6, 8.2, 10.3, and 8.6 cases per 1000 individuals respectively. 
In the subgroup analysis by age group, age under 5 was the most valuable group for ‘influenza outpatients’ 
and in-patient admission due to ‘pneumonia and influenza’ and ‘SARI’.  In the subgroup analysis by 
geographical location, Jeollanamdo, Gyeongsangnamdo, and Gwangju were showed the highest incidence 
rate of admitted patients due to ‘pneumonia and influenza’ and ‘SARI’ for 7 years.  
Conclusions The burden of seasonal influenza was varied by year and also differ from age and 
geographical location. The temporal and spatial variation of seasonal influenza suggested that monitoring 
temporal trends seasonal influenza activity by different subpopulation level is needed. Public health 
preparedness should be implemented to reduce the burden from seasonal influenza on those sub-





Influenza is a common but a serious re-emerging acute infectious disease with its social and health 
impact1. Even though most of the influenza infections present as asymptomatic infections or mild 
symptomatic illness2,3, there are still many numbers of individuals suffer from severe infections and 
resulted in deaths every year. Previous research suggests that one-fifth of children and one-twentieth of 
adults in the world experienced symptomatic influenza every year4,5. Hospitalization and death due to 
seasonal influenza mainly occur among people with high-risk factors such as young age, pregnancy, people 
living with HIV/AIDS, diabetes or hematologic conditions, liver disease or asthma6–9. 
The burden of seasonal influenza illness is tremendous. A recent study re-estimated that severe illness 
is about 3 to 5 million cases, and the number of deaths is 250,000 to 500,000 events per year globally5. 
The US Centers for Disease Control and Prevention estimated that in the United States during the 2016-
17 season, there were 14.5 million medical visits including over 600 000 hospitalizations due to influenza 
among 30.9 million disease illness10. In South Korea, it is estimated that laboratory-confirmed influenza 
was 97,819 cases, and among them 23.8%, 23,327 cases were hospitalization and 1.3%, 1,249 cases 
resulted in death in specific adult population in Korea during the 2013-14 season11.   
The World Health Organization emphasized the importance of disease burden estimates through the 
surveillance system. They said that there is “a need for reliable disease burden estimates to provide a 
better understanding of the impact of influenza in vulnerable communities and subpopulation.”12  
Moreover, it stated that those reliable estimates will be able to governments make evidence-based 
decisions by allocating health resources and developing strategies to control the transmission of the 
disease and to reduce the medical and economical burdens.  
By the definition, surveillance systems are systematic collection of disease for estimating disease 
burden and aberration of its activity to increase rapid response to the outbreak 13. However, the current 
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influenza surveillance system in South Korea could not meet one of those objectives14,15. It is hard to 
estimate actual number of illness in the country. Even though South Korea have been using a proportion 
of influenzas-like-illness patients as metrics for influenza surveillance, source population in the 
surveillance are not fully representative from the entire population and we could not define the 
population at risk precisely. The current influenza surveillance systems in South Korea use convenient 
sentinel sites or some selected emergency departments in tertiary hospitals. Those sites are useful for 
administrative convenience and collecting a data but those sentinels could not provide more detailed 
information on influenza disease burden by age groups or geographical locations due to lack of sample 
size for stratification. 
Therefore, in this paper, we suggest to use newly developed approach to estimate the burden of 
seasonal in South Korea. We will apply different case definitions based on diagnostic codes through billing 
information in the national health insurance system. This approach will enable to estimate the burden of 
seasonal influenza more precisely and can provide stratified disease burden based on age groups and 
geographical subdivisions. 
Methods  
We used National Health Information Database (NHID) of the National Health Insurance Service16. 
South Korea has a national-wide, mandatory, universal, single-payer and electronic health insurance 
system and it covers more than 99% of the population in South Korea. NHID is providing most of Korea 
residents’ (approximately 50 million individuals) insurance eligibility, medical treatment records, provider 
institution, general medical/health examination. 
In this analysis, we mostly focus on two of a sub-database of ‘medical treatment database.’ We used 
a section called ‘details of diseases’ for disease burden estimation and linked ‘insurance eligibility 
database’ to estimate burden for epidemiological risk profile. In ‘details of the disease,’ we integrated 
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individuals’ date of medical visit, characteristics of medical visit (outpatient/inpatient), diagnosis codes 
(based on the Korean Classification Diseases 5 & 6-KCD 5&6), and clinics’ information (internal medicine, 
emergency department, etc.).  In ‘insurance eligibility,’ we merged individuals age, gender and 
geographical location (ISO 3166-2, the principal subdivisions - provinces or states) to claim data. Due to a 
large number of individuals and confidentiality issue, we chose stratified random selection from the entire 
participated from the National Health Information Database. Which resulted in approximately 2% of 
participants are from the whole eligible Korean residents.  
The study population was total 1,084,673 from January 1st, 2006 to December 31st, 2013. We defined 
a surveillance season year as from current years’ 36th week to following years’ 35th week. Therefore, we 
used the billing information from 36th-week of 2006 to 35th-week of 2013 for the general estimation 
which is relevant from the 2006 influenza season to 2012 influenza season.  
We used the Korean Classification Diseases 5 which is a localized version of the International 
Classification of Disease 10 to estimate the number of seasonal influenza illness. We defined influenza 
outpatient activity as diagnosis code J09, J10, and J11 in billing information from an outpatient visit with 
relevant specialties17,18. For severe cases of influenza-related illness, we used different combinations of 
disease diagnosis code which are already discussed by other researchers. We used definitions from 
influenza (J09-J11) to pneumonia (J12-J18) in admitted patients to correspond to pneumonia and 
influenza-related admission19,20.  We also included other acute lower respiratory infections (J20-J22) to 
account severe acute respiratory illness (SARI) 21,22. For the base case definition, we only applied those 
codes to the primary diagnosis code. For extended case definition, we also used those code to secondary 
diagnosis in billing information. [Figure 2-1]   
We observed repeated billing information with the same diagnosis codes from the same individuals 
for a certain amount of time. If billing was processed from the same individuals from the same institute 
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with the same diagnosis codes within three weeks, we consider those multiple billings were originated by 
a single illness and included the only first billing information to estimate case burden and exclude the rest 
of them from estimation. 
Even though most of the influenza illness and its related respiratory illness were diagnosed at the 
general physician, internal medicine, family medicine, pediatrics, emergency department, and 
otolaryngology, we observed few cases of pneumonia and influenza admission and SARI from other 
medical departments. Therefore, we primarily used the billing information from General Practitioner 
(doctors without specialty in Korea), Internal Medicine, Family Medicine, Pediatrics, Emergency Medicine 
and Otolaryngology. 
South Korea declare Se-jong City, which is relevant ISO 3166-2; principal subdivisions, in 2012, July 1st 
as an administrative capital city of South Korea. Since 2012, July, many counties integrated to Se-jong City 
from other provinces by multiple time points and the population of Se-jong increased during this transition 
time23. Due to the complex of geographical region dynamics and uncertain population status, we decide 
to exclude Se-jong City in state-level stratification analysis in this study.    
During the 2009-2010 season, South Korea experienced 2009 Pandemic Influenza which expect to 
have outnumbered influenza out-patient cases in observation. The Korean Center for Disease Control and 
Prevention’s report said that during the 2009 pandemic season, the number of cases is outnumbered 
15,000 cases of October 12th, 200924. Therefore, we exclude the 2009 - 2010 season (36th week of 2009 
to 35th week of 2010) among influenza out-patient cases in the analysis.  
For more detailed information on the case burden of influenza, we stratified our national level 
estimation into various subpopulation. In the age categories, we follow the World Health Organization 
guideline12. We decide individuals’ age in the middle of the seasonal influenza year, which is the last day 
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of December, and categorized them into five different age groups (from 0-5, 5-15,16-50,50-65, and 65 
above). Geographical subdivisions follow the lasted 17 geographical and political divisions which were 
revised in the year 2012 (but excluded Se-jong city). The population at risk is calculated as in the middle 
of the seasonal influenza year, (the last day of December). To adjust the demographic difference, we used 
the direct age-standardized method25. As the WHO guided, we used a new standard based on the 
projected 2000 population age distribution26.  
Results 
We reviewed total 1,084,673 individuals’ billing information from the 2006-07 season to 2012-13 
season which is approximately 1,000,000 individuals every year. The number of individuals at age under 
five slightly increased during the study period while the number of individuals at the age between 5 to 15 
and age between 16-50 decreased. However, the number of individuals at the age between 51-65 and 
over 65 increased almost 25 percent during the study period (Table 2-1).  
The number of influenza outpatient ranged from 3,662 cases to 9,666 cases (except pandemic year), 
which is equivalent 3.6 to 9.5 cases per 1,000 individuals in crude incidence and 4.7 to 13.8 cases per 1,000 
individuals in age-standardized incidence. For the pandemic year, the number of influenza outpatient was 
59,975, then 60.1 and 78.0 cases per 1,000 individuals in crude and age-standardized incidence.  
The number of pneumonia and influenza in-patients (PNIADM)and severe acute respiratory infection 
(SARI) were 4,265 to 8,547 and 5,502 to 10,365 cases. Crude incidence ranged from 4.1 to 8.5 cases per 
1,000 individuals for PNIADM and 5.2 to 10.3 cases per 1,000 individuals for SARI. Age-standardized 




During the study time, exclude pandemic year, the lowest incidence of influenza outpatient by 
geographical subdivision level was 1.9 cases per 1,000 individuals (Seoul at season 2012), and the highest 
incidence of influenza was 16.4 cases per 1,000 individuals (Chungnam at season 2006) in crude. In age-
standardized incidence, the lowest was 2.4 (Jeju at season 2012) cases per 1,000 individuals and the 
highest was 26.2 cases per 1,000 individuals (Ulsan at season 2011). For PNIADM and SARI incidence by 
subdivision level, the lowest crude incidence was 2.6 cases (Incheon at season 2008, PNIADM) and 3.1 
(Incheon at season 2007, SARI) per 1,000 individuals and the highest crude incidence were 18.4 cases 
(Joennam season 2012, PNIADM and 25.1 (Joennam at season 2012, SARI) per 1,000 individuals. After 
age-standardized, the lowest incidence was 3.5 cases (Incheon at season 2008) per 1,000 individuals for 
PNIADM and 4.5 (Incheon at season 2007) cases per 1,000 individuals for SARI. The highest incidence was 
25.1 cases (Joennam at season 2012) per 1,000 individuals for PNIADM and 35.4 cases (Joennam at season 
2012) per 1,000 individuals for SARI.  
In 3-years average age-adjusted annual incidence by subdivision level, Incheon showed the lowest 
incidence for influenza out-patients, and Seoul showed the lowest incidence for PNIADM and SARI. While 
JeonBuk showed the highest incidence for influenza out-patients while JeonNam showed the highest 
incidence for PNIADM and SARI.   
In subgroup analysis, we performed the incidence ratio comparison between base case definitions 
and extended case definitions. Incidence ratio of influenza outpatients case definitions was ranged from 
1.15 to 1.31 in over-all age group comparison. But after age stratification, the interval was increased as 
the lowest ratio was 1.07 (age over 65 at season 2008), and the highest ratio was 2.00 (Age under 5 at 
season 2006). For PNIADM, the incidence ratio ranged from 1.29 to 1.40 in over-all age group and ranged 
from 1.19 (Age under 5 at season 2011) to 1.76 (Age over 65 at season 2006) after age-stratification. For 
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SARI, the ratio started from 1.32 to 1.47 in over-all age group comparison and varied from 1.22 (Age 5-15 
at season 2011) to 1.77 (Age over 65 at season 2006) in age-stratification.  
Discussion  
In this study, we estimated a practice-oriented disease burden based on diagnosis codes in the billing 
information from the national health insurance system. We were able to calculate population-based cases 
and incidence rates at the national level and state-level with age stratification and standardization. We 
observed the different disease incidence rate by age-group and found the unequal distribution of disease 
by state-level.  
We observed a shift in population distribution. Beginning of the study, we have more individuals 
among age 5-15 then age over 65, but at the end of the study, we have more individuals among age over 
65 than age 5-15. Moreover, the number of individuals in the age group 51-65 have increased by 33% 
during the study period. All of those observations implied that a simple comparison of the case number 
and crude incidence might not be valid even though the study period was only 7 years.   
For annual incidence of influenza out-patient, we observed two seasons with relatively high incidence 
compare to the other season. First high peak season was on the worldwide pandemic influenza at the year 
2009-201027. The second highest incidence was at season 2011 which is not related to pandemic influenza. 
This could be the results from a mismatch for influenza B and low vaccine efficacy for influenza A, 
especially H3N, from the 2011-12 season in South Korea or extremally cold weather in January, which is 
normally considered highly transmitted time of seasonal influenza28,29. Base on this result we concluded 
that the burden of influenza could be different year by year even without pandemic influence, and the 
magnitude of disease burden could be tripled compared to the regular season.  
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There were significant changes in the number of diagnoses especially in influenza out-patient by the 
point of pandemic especially age under 5 and over 65. Before the pandemic, the highest incidence by age 
group was age over 65, then age 51 and 65. But after the pandemic, the highest incidence was age under 
5, then age 6 and 15. To determine the reason for this pattern changes, we compare the ratio between 
influenza in-patient and influenza outpatient and the ratio between influenza outpatient and pneumonia 
and influenza outpatient. The ratio between influenza in-patient and influenza outpatient were increased 
among age under 5 and age over 65 together after the pandemic. But the ratio influenza outpatient and 
pneumonia and influenza outpatient were increased at the age under 5 and decreased at the age over 65. 
Moreover, the incidence of PNIADM and SARI were increased after pandemic while the incidence of 
influenza outpatient was deceased. This implied that age over 65 over-diagnosed as influenza over 
pneumonia before the pandemic, but that tendency was diminished after 2009 pandemic. The potential 
cause of these pattern changes in age under 5 could be due to the rise of awareness of influenza among 
pediatricians and parents of younger children after pandemic influenza.  
We observed the difference of disease burden by sex in severe influenza cases. For pneumonia and 
influenza in-patient, male normally showed higher incidence compared to the female at the age under 5. 
But after age 5, females showed higher incidence compared to the male until age 50, then flip the 
relationship again. For SARI, males showed higher incidence at the age of 15, then it flipped until age 50, 
and flipped again after age 50. The change of incidence between boys and girls at a certain young age 
followed observations in previous literature30–32. Moreover higher incidence of pneumonia and influenza 
and severe acute respiratory illness among men over age 50 can be explained by risky behaviors of men 
such as alcoholism and nicotine33.   
We also observed the unequal distribution of disease burden by geographical subdivision stratification. 
For 3-year-average age-adjusted annual incidence, Jeonbuk showed the 3 times higher influenza out-
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patient incidence rate compared to Incheon, the lowest subdivision. For PNIADM and SARI, Gwangju and 
JeonNam showed the highest incidence among 16 states. People normally consider that the highest 
population density is a risk factor for respiratory infections transmission, but in this analysis, the highest 
density areas, Seoul and Gyeonggi, actually showed lower incidence compared to the other areas. This 
can be explained in 2 different ways. First, a crowding as a risk factor from the literature defined as how 
many people stayed in one single house, or how many children do you have in your family34–36. The 
effective population density is not an aggregate-level calculated from the number of people divided by a 
size of the area. In this case, the Capital Seoul Area (Seoul, Gyeonggi, and Incheon) has more single families 
and smaller size of family compared to the other suburban and rural area where have more extended 
families with a larger family member. This definition of population density in infectious disease, or house 
crowding, can explain the reason why the Capital Seoul Area showed a lower incidence compared to other 
geographical subdivision. The other explanation is early initiation of influenza treatment. Since 2009 
pandemic influenza, the Ministry of Health and Welfare and the National Health Insurance increased a 
coverage on the cost of treatment on influenza, such as prescription of oseltamivir with confirmed rapid 
diagnosis1,37. This policy implementation made the early initiation of influenza treatment possible and this 
implementation mostly happened in politically and economically centered area, the Capital Seoul Area 
which resulted reduce the transmission of influenza. New policy implementation in large population 
centered area also can be one of the reasons why those areas have a lower incidence. Moreover, a recent 
study also supports that a large population is acting like a modulate rather than a driven factor of influenza 
intensity38. On that paper, Tauranga emphasized that rural area needs to more focus on severe influenza 
cases than mild symptoms with a rapid transmission39. We observed that JeonNam and GyeonNam ranked 




Extended case definition can be used in disease burden estimation also. We performed a sensitivity 
analysis of base and extended case definitions for FLUOPD, PNIADM, and SARI. The base and extended 
case ratio was a quite difference year by year before the pandemic but became stable in temporal trends 
after the pandemic. However, the ratio was not the same through the age group regardless of the 
pandemic event. This implied us we might use the extend case definition to estimate disease burden more 
wide definition but cannot just apply one simple multiplier to get extended case definition. Age 
distribution and disease intensity need to be considered before applying a single multiplier to calculate 
extended disease burden estimation.  
This study has multiple strengths.  First, this study provided original estimates of the number of 
influenza out-patients and severe cases directly, not as a proportion of cases. Current influenza 
surveillance system in South Korea and most of influenza surveillance system in the other countries are 
based on sentinels where we cannot define the population at risk40. That sentinel surveillance setting 
could not provide the number of cases, the incidence of influenza and its related illness. Using 
systematically sampled population allowed us to estimate the actual population at risk so that we could 
provide the actual number and the incidence of influenza as a disease burden. This approach will make 
public health professionals understand the distribution of disease and intensity of disease more precisely 
and lead them to establish a more informed public health preparedness program. 
Second, this study provided estimates of influenza burden by geographical subdivisions and different 
age categories. Current influenza systems do not have enough sentinels to provide stratified estimates of 
influenza and its related illness. However, a million of national sample cohort guides to provide the 
estimates of influenza and its related illness at the subdivision, where different influenza prevention policy 
can be implemented, and 5 different age categories as the World Health Organization suggested in its 
guideline12. Based on this information, the Korea government could develop revised influenza prevention 
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and control strategy to reduce the burden of influenza. Some geographical subdivision with higher 
influenza burden needs more intervention to reduce the transmission or outpatient visits through 
increased vaccination or early initiation of influenza treatment. Free influenza vaccination campaigns in 
South Korea in age over 65 and under 5 also complied with this analysis.  
Lastly, it shows the potential possibility to use billing information as a supportive system for seasonal 
influenza surveillance. Until recent days, influenza surveillance systems are based on syndromic 
surveillance methods such as influenza-like illness at the Emergency Department or sentinel sites, 
proportion and strains of influenza laboratory diagnosis, or mortality rate due to influenza and 
pneumonia40. However, this approach helps us to use billing information to be another pillar of the 
influenza surveillance system. With nationwide, universal, electric, and mandatory insurance system, we 
can use billing information as another disease surveillance source.  
Still, there are limitations. First, cases in the study were from practice-oriented cases, not actual 
people who are infected. The individuals in the study who classified as influenza and its related illness 
were diagnosed persons by the health care facility. Therefore, we could not estimate the number of 
individuals who developed mild symptoms which don’t need to come to a medical facility or of individuals 
who cannot come to the medical facility. There is a chance we still underestimate the number of cases 
and incidence.  
Second, disease diagnosed codes are formed for billing purpose, not surveillance purpose. Even 
though billing information provided a great number and nourished information of individuals, those are 
constructed for the billing process. Even though the World Health Organization states that the 
International Statistical Classification of Diseases and Related Health Problems is designed for "standard 
diagnostic tool for epidemiology, health management, and clinical purposes.", South Korean government 
and medical doctors used this tool for the billing process. This may lead to seeing us misdiagnosed or 
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miscoded individuals due to insurance eligibility and its coverage. Therefore, there are chances to over or 
underestimates the burden from the truth. However, practice-oriented disease burden estimation and 
costs will remain the same.   
Third, there is a need for clear definition of disease burden.  In this paper, we used annual cumulative 
disease cases per 100,000 individuals as a disease burden. However, traditionally disease burden is 
defined a prevalence of disease in certain population which hard to be applied short cycle infectious 
disease. Moreover, cases per 100,000 individuals is a relative measurement. Even though, the Capital 
Seoul Area showed the lowest disease burden in “annual cases per 100,000 individuals”. In a view of total 
number of influenza patient in the region, the Capital Seoul Area has the greatest disease burden (the 
largest patients). More clear and precise definition of disease burden in short cycle infectious disease may 
need to be discussed in future papers.   
Lastly, a verification process needs to be done. We used billing information as surveillance source, but 
it only provided a number and incidence of influenza at year unit. Since surveillance also needs to use the 
data source to monitor temporal trends of influenza activity, timeliness validation of this approach needs 
to be done to use of this information in other purposes surveillance such as temporal trends monitoring 




































































































































Figure 2-1. Case definitions by the International Statistical Classification of Diseases and Related Health Problems 10 / 
Korean Standard Classification of Diseases-5  







Infections   
(In Patient) 
Diseases of the respiratory system (J00-J99)    
J09-J11 Influenza and Pneumonia    
J09-J11 Influenza and Pneumonia    
J09 Influenza due to specific identified influenza virus O O O 
J10 Influenza due to other identified influenza virus O O O 
J11 Influenza, virus not identified O O O 
J12-J18 Pneumonia diagnosis group    
J12 Viral pneumonia, NEC  O O 
J13 Pneumonia due to Streptococcus pneumoniae  O O 
J14 Pneumonia due to Haemophilus influenza  O O 
J15 Bacterial pneumonia, NEC  O O 
J16 Pneumonia due to other infectious organisms, NEC  O O 
J17 Pneumonia in diseases classified elsewhere  O O 
J18 Pneumonia, organism unspecified  O O 
J20-J22 Other acute lower respiratory infections    
J20 Acute bronchitis   O 
J21 Acute bronchiolitis   O 
J22 Unspecified acute lower respiratory infection   O 
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Table 2-1. Study population by age-group during 2006-2013 season 

















Age under 5 43,592 44,229 43,437 42,673 43,206 45,355 45,906 
Age 5-15 138,209 134,070 125,178 118,677 111,972 105,698 101,397 
Age 16-50 566,227 573,752 559,333 552,798 547,768 542,247 537,642 
Age 51-65 155,432 162,841 166,183 174,384 185,650 195,805 203,153 
Age over 65 98,545 105,851 106,654 109,995 113,435 117,376 123,025 





 Table 2-2. The number of seasonal influenza out-patient, pneumonia and influenza in-patient, and severe acute respiratory illness in South Korea during 2006-2013 
season 
 Age Category 06-07 Season 07-08 Season 08-09 Season 09-10 Season* 10-11 Season 11-12 Season 12-13 Season 
Influenza  
Out Patient  
Age under 5 235 359 429 8,029 653 2,779 777 
Age 5-15 436 609 804 20,169 1,008 2,672 785 
Age 16-50 2,023 2,202 2,323 25,818 2,202 2,610 1,419 
Age 51-65 1,484 1,562 1,582 3,471 684 932 424 
Age over 65 2,648 3,090 3,472 2,488 367 562 257 
Total  6,826 7,822 8,610 59,975 4,914 9,555 3,662 
Pneumonia 
and Influenza  
In Patient 
Age under 5 2,062 1,967 1,979 2,700 2,769 3,535 2,910 
Age 5-15 635 413 386 891 930 1,143 512 
Age 16-50 414 415 405 692 713 872 595 
Age 51-65 296 338 342 438 572 736 656 
Age over 65 858 1,102 1,112 1,327 1,702 2,261 2,179 
Total  4,265 4,235 4,224 6,048 6,686 8,547 6,852 
SARI 
In Patient  
Age under 5 2,621 2,626 2,690 3,568 3,597 4,504 3,934 
Age 5-15 730 527 533 1,070 1,082 1,349 688 
Age 16-50 548 589 613 920 952 1,128 848 
Age 51-65 364 407 444 543 707 915 830 
Age over 65 927 1,187 1,222 1,446 1,856 2,469 2,370 





Table 2-3. The annual incidence of seasonal influenza out-patient in South Korea during 2006-2013 season by age and sex. 
 Age Category 06-07 Season 07-08 Season 08-09 Season 09-10 Season* 10-11 Season 11-12 Season 12-13 Season 
Influenza  
Out Patient  
Age under 5 5.4 (4.7-6.1) 8.1 (7.3-9) 9.9 (8.9-10.8) 188.2 (184.4-
191.9) 
15.1 (14-16.3) 61.3 (59.1-63.5) 16.9 (15.7-18.1) 
Age 5-15 3.2 (2.9-3.5) 4.5 (4.2-4.9) 6.4 (6-6.9) 169.9 ( 67.8-
172.1) 
9 (8.4-9.6) 25.3 (24.3-26.2) 7.7 (7.2-8.3) 
Age 16-50 3.6 (3.4-3.7) 3.8 (3.7-4) 4.2 (4-4.3) 46.7 (46.1-47 3 4 (3.9-4.2) 4.8 (4.6-5) 2.6 (2.5-2.8) 
Age 51-65 9.5 (9.1-10) 9.6 (9.1-10.1) 9.5 (9.1-10) 19.9 (19.2-20.6) 3.7 (3.4-4) 4.8 (4.5-5.1) 2.1 (1.9-2.3) 
Age over 65 26.9 (25.9-27.9) 29.2 (28.2-30.2) 32.6 (31.5-33.6) 22.6 (21.7-23.5) 3.2 (2.9-3.6) 4.8 (4.4-5.2) 2.1 (1.8-2.3) 
Crude Overall  6.8 (6.7-7) 7.7 (7.5-7.8) 8.6 (8.4-8.8) 60.1 (59.6-60.5) 4.9 (4.8-5) 9.5 (9.3-9.7) 3.6 (3.5-3.7) 




Age under 5 5.2 (4.3-6.1) 7.7 (6.6-8.9) 10.2 (8.9-11.5) 190.6 (185.5-
195.8) 
14.7 (13.1-16.3) 61.2 (58.2-64.3) 17.3 (15.7-19) 
Age 5-15 3.1 (2.7-3.5) 4.4 (3.9-4.9) 6 (5.4-6.6) 172.9 (170-
175.9) 
8.4 (7.6-9.1) 24.6 (23.3-25.9) 7.5 (6.7-8.2) 
Age 16-50 3 (2.8-3.2) 3.1 (2.9-3.3) 3.4 (3.2-3.7) 43.8 (43-44 5 3.6 (3.3-3.8) 4.1 (3.8-4.3) 2.3 (2.1-2.5) 
Age 51-65 6.3 (5.8-6.9) 6.1 (5.6-6.7) 6.2 (5.7-6.7) 15.3 (14.4-16.1) 3 (2.6-3.3) 3.9 (3.5-4.3) 1.8 (1.5-2) 
Age over 65 20.3 (18.9-21.7) 20.8 (19.5-22.2) 21.9 (20.5-23.2) 18.7 (17.5-20) 2.9 (2.4-3.4) 4 (3.5-4.6) 2 (1.6-2.4) 
Crude Overall  5 (4.8-5.2) 5.5 (5.3-5.7) 6.1 (5.9-6.3) 59.1 (58.5-59.8) 4.4 (4.3-4.6) 8.9 (8.7-9.2) 3.4 (3.3-3.6) 




Age under 5 5.6 (4.6-6.6) 8.5 (7.3-9.8) 9.5 (8.2-10.9) 185.5 (180.2-
190.8) 
15.5 (13.9-17.2) 61.3 (58.1-64.5) 16.5 (14.8-18.2) 
Age 5-15 3.2 (2.8-3.6) 4.7 (4.1-5.2) 6.9 (6.2-7.6) 166.7 ( 63 6-
169.7) 
9.7 (8.9-10.5) 26 (24.6-27.4) 8 (7.2-8.8) 
Age 16-50 4.2 (3.9-4.4) 4.6 (4.3-4.8) 4.9 (4.6-5.2) 49.8 (49-50 6 4.5 (4.2-4.8) 5.6 (5.3-5.9) 3 (2.8-3.2) 
Age 51-65 12.7 (11.9-13.5) 13 (12.2-13.8) 12.8 (12.1-13.6) 24.6 (23.5-25.6) 4.4 (4-4.8) 5.6 (5.1-6.1) 2.4 (2.1-2.7) 
Age over 65 31.2 (29.8-32.6) 34.8 (33.4-36.2) 39.9 (38.3-41.4) 25.3 (24.1-26.5) 3.5 (3-3.9) 5.3 (4.8-5.9) 2.2 (1.8-2.5) 
Crude Overall  8.6 (8.4-8.9) 9.9 (9.6-10.1) 11.1 (10.8-11.4) 61 (60.3-61.7) 5.4 (5.2-5.6) 10.1 (9.8-10.3) 3.8 (3.7-4) 





Table 2-4. The annual incidence of pneumonia and influenza in-patient in South Korea during 2006-2013 season by age and sex. 





Age under 5 47.3 (45.3-49.3) 44.5 (42.6-46.4) 45.6 (43.6-47.5) 63.3 (61-65.6) 64.1 (61.8-66.4) 77.9 (75.5-80.4) 63.4 (61.2-65.6) 
Age 5-15 4.6 (4.2-5) 3.1 (2.8-3.4) 3.1 (2.8-3.4) 7.5 (7-8) 8.3 (7.8-8.8) 10.8 (10.2-11.4) 5 (4.6-5.5) 
Age 16-50 0.7 (0.7-0.8) 0.7 (0.7-0.8) 0.7 (0.7-0.8) 1.3 (1.2-1.3) 1.3 (1.2-1.4) 1.6 (1.5-1.7) 1.1 (1-1.2) 
Age 51-65 1.9 (1.7-2.1) 2.1 (1.9-2.3) 2.1 (1.8-2.3) 2.5 (2.3-2.7) 3.1 (2.8-3.3) 3.8 (3.5-4) 3.2 (3-3.5) 
Age over 65 8.7 (8.1-9.3) 10.4 (9.8-11) 10.4 (9.8-11) 12.1 (11.4-12.7) 15 (14.3-15.7) 19.3 (18.5-20) 17.7 (17-18.4) 
Crude Overall  4.3 (4.1-4.4) 4.1 (4-4.3) 4.2 (4.1-4.3) 6.1 (5.9-6.2) 6.7 (6.5-6.8) 8.5 (8.3-8.7) 6.8 (6.6-6.9) 






Age under 5 49.9 (47.1-52.8) 47.6 (44.9-50.4) 47.5 (44.8-50.3) 68 (64.7-71.3) 65.8 (62.6-69.1) 81.2 (77.7-84.7) 64.5 (61.3-67.6) 
Age 5-15 4.4 (3.9-4.9) 3.3 (2.8-3.7) 2.9 (2.5-3.3) 8.1 (7.4-8.8) 8.7 (8-9.5) 10.4 (9.5-11.2) 5 (4.4-5.6) 
Age 16-50 0.7 (0.6-0.8) 0.6 (0.6-0.7) 0.7 (0.6-0.8) 1.1 (1-1.2) 1.2 (1.1-1.3) 1.3 (1.1-1.4) 1 (0.9-1.1) 
Age 51-65 2 (1.7-2.3) 2.2 (1.8-2.5) 1.9 (1.6-2.2) 2.5 (2.2-2.8) 3.3 (2.9-3.6) 3.6 (3.2-4) 3 (2.7-3.4) 
Age over 65 11.4 (10.4-12.5) 12.9 (11.9-14) 14.3 (13.2-15.4) 15.7 (14.6-16.9) 18.2 (17-19.4) 22.6 (21.3-23.9) 22.2 (21-23.5) 
Crude Overall  4.5 (4.3-4.7) 4.4 (4.2-4.6) 4.4 (4.3-4.6) 6.5 (6.3-6.7) 6.9 (6.7-7.1) 8.5 (8.2-8.7) 6.9 (6.7-7.1) 






Age under 5 44.5 (41.7-47.3) 41.1 (38.4-43.7) 43.4 (40.7-46.2) 58.2 (55-61.4) 62.2 (59-65.5) 74.5 (71-78) 62.3 (59.1-65.4) 
Age 5-15 4.8 (4.3-5.4) 2.9 (2.5-3.3) 3.3 (2.9-3.8) 6.8 (6.2-7.5) 7.9 (7.1-8.6) 11.3 (10.4-12.2) 5.1 (4.5-5.7) 
Age 16-50 0.8 (0.7-0.9) 0.8 (0.7-0.9) 0.8 (0.7-0.9) 1.4 (1.3-1.5) 1.4 (1.3-1.5) 2 (1.8-2.1) 1.2 (1.1-1.4) 
Age 51-65 1.8 (1.5-2.1) 2 (1.7-2.3) 2.3 (1.9-2.6) 2.5 (2.2-2.9) 2.9 (2.5-3.2) 3.9 (3.5-4.3) 3.4 (3.1-3.8) 
Age over 65 6.9 (6.3-7.6) 8.7 (8-9.4) 7.8 (7.1-8.5) 9.5 (8.8-10.3) 12.8 (12-13.7) 16.9 (16-17.9) 14.5 (13.6-15.4) 
Crude Overall  4 (3.9-4.2) 3.9 (3.7-4.1) 4 (3.8-4.2) 5.6 (5.4-5.8) 6.4 (6.2-6.7) 8.5 (8.3-8.8) 6.6 (6.4-6.9) 
Age-Adjusted* 6.1 (5.8-6.3) 5.5 (5.3-5.8) 5.8 (5.5-6.1) 8.3 (8-8.6) 9.1 (8.8-9.5) 11.6 (11.2-12) 8.6 (8.3-9) 
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Table 2-5. The annual incidence of severe acute respiratory illness in South Korea during 2006-2013 season by age and sex. 





Age under 5 60.1 (57.9-62.4) 59.4 (57.2-61.6) 61.9 (59.7-64.2) 83.6 (81-86.2) 83.3 (80.6-85.9) 99.3 (96.6-102.1) 85.7 (83.1-88.3) 
Age 5-15 5.3 (4.9-5.7) 3.9 (3.6-4.3) 4.3 (3.9-4.6) 9 (8.5-9.6) 9.7 (9.1-10.2) 12.8 (12.1-13.4) 6.8 (6.3-7.3) 
Age 16-50 1 (0.9-1) 1 (0.9-1.1) 1.1 (1-1.2) 1.7 (1.6-1.8) 1.7 (1.6-1.8) 2.1 (2-2.2) 1.6 (1.5-1.7) 
Age 51-65 2.3 (2.1-2.6) 2.5 (2.3-2.7) 2.7 (2.4-2.9) 3.1 (2.9-3.4) 3.8 (3.5-4.1) 4.7 (4.4-5) 4.1 (3.8-4.4) 
Age over 65 9.4 (8.8-10) 11.2 (10.6-11.8) 11.5 (10.8-12.1) 13.1 (12.5-13.8) 16.4 (15.6-17.1) 21 (20.2-21.9) 19.3 (18.5-20) 
Crude Overall 5.2 (5-5.3) 5.2 (5.1-5.4) 5.5 (5.4-5.6) 7.6 (7.4-7.7) 8.2 (8-8.4) 10.3 (10.1-10.5) 8.6 (8.4-8.8) 






Age under 5 64.4 (61.3-67.6) 64.1 (60.9-67.2) 66.3 (63-69.5) 91.3 (87.5-95.1) 87.3 (83.6-91) 105.1 (101-109) 89.3 (85.7-92.9) 
Age 5-15 5.1 (4.6-5.6) 4.2 (3.7-4.7) 4.2 (3.7-4.6) 9.7 (9-10.5) 10 (9.2-10.9) 12.4 (11.5-13.4) 6.9 (6.2-7.6) 
Age 16-50 0.9 (0.7-1) 0.9 (0.8-1) 1 (0.8-1.1) 1.4 (1.3-1.6) 1.6 (1.4-1.7) 1.6 (1.5-1.8) 1.4 (1.2-1.5) 
Age 51-65 2.4 (2-2.7) 2.4 (2.1-2.8) 2.3 (1.9-2.6) 3 (2.6-3.3) 3.8 (3.4-4.2) 4.3 (3.9-4.7) 3.7 (3.3-4.1) 
Age over 65 12 (10.9-13) 13.6 (12.5-14.7) 15 (13.9-16.2) 16.6 (15.4-17.8) 19.4 (18.2-20.7) 24.2 (22.8-25.5) 23.5 (22.2-24.9) 
Crude Overall 5.5 (5.2-5.7) 5.5 (5.3-5.7) 5.7 (5.5-5.9) 8.1 (7.8-8.3) 8.4 (8.2-8.7) 10.3 (10-10.6) 8.8 (8.5-9) 






Age under 5 55.4 (52.3-58.5) 54.3 (51.3-57.4) 57.3 (54.1-60.4) 75.4 (71.8-79) 78.9 (75.3-82.6) 93.2 (89.4-97) 81.9 (78.3-85.5) 
Age 5-15 5.5 (4.9-6) 3.6 (3.1-4.1) 4.4 (3.8-4.9) 8.2 (7.5-9) 9.2 (8.4-10.1) 13.1 (12.1-14.1) 6.6 (5.9-7.3) 
Age 16-50 1.1 (1-1.2) 1.2 (1-1.3) 1.2 (1.1-1.4) 1.9 (1.7-2.1) 1.9 (1.7-2.1) 2.5 (2.4-2.7) 1.8 (1.7-2) 
Age 51-65 2.3 (2-2.6) 2.6 (2.2-2.9) 3.1 (2.7-3.5) 3.3 (2.9-3.6) 3.9 (3.5-4.2) 5.1 (4.6-5.5) 4.5 (4.1-4.9) 
Age over 65 7.7 (7-8.4) 9.6 (8.8-10.4) 9 (8.3-9.7) 10.8 (10-11.6) 14.2 (13.3-15.1) 18.8 (17.8-19.9) 16.2 (15.3-17.2) 
Crude Overall 4.9 (4.7-5.1) 5 (4.8-5.2) 5.3 (5.1-5.5) 7 (6.8-7.3) 7.9 (7.7-8.2) 10.3 (10-10.6) 8.4 (8.1-8.6) 
Age-Adjusted* 7.5 (7.2-7.8) 7.1 (6.8-7.4) 7.6 (7.3-8) 10.6 (10.2-10.9) 11.4 (11-11.7) 14.2 (13.8-14.6) 11.2 (10.8-11.6) 
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Table 2-6. Crude and Age-Adjusted Annual Incidence (per 1,000) of seasonal influenza out-patient in South Korea during 2006-2013 season by subdivision level.   
  06-07 Season 07-08 Season 08-09 Season 09-10 Season 10-11 Season 11-12 Season 12-13 Season 
Crude 
Seoul 3.9 (3.6-4.1) 5.6 (5.3-5.9) 6.9 (6.6-7.3) 57.4 (56.4-58.4) 3.4 (3.1-3.6) 6.5 (6.1-6.8) 1.9 (1.7-2.1) 
Busan 5 (4.5-5.5) 7.7 (7-8.3) 6.7 (6.1-7.3) 52.5 (50.9-54.2) 4.7 (4.2-5.2) 9.6 (8.9-10.3) 4.3 (3.8-4.8) 
Daegu 4.2 (3.7-4.8) 5 (4.4-5.6) 5.5 (4.9-6.2) 52 (50.1-54) 3.5 (2.9-4) 7.4 (6.6-8.1) 3 (2.6-3.5) 
Incheon 6.3 (5.7-7) 6.6 (5.9-7.3) 7.3 (6.6-8) 61.8 (59.8-63.8) 3 (2.5-3.5) 6.7 (6.1-7.4) 2.1 (1.7-2.5) 
Gwangju 7.3 (6.3-8.2) 8.7 (7.6-9.7) 10 (8.9-11.2) 66.1 (63.2-69) 8.1 (7.1-9.1) 15.4 (14-16.7) 9.9 (8.8-11.1) 
Daejeon 6.7 (5.7-7.6) 9.3 (8.2-10.3) 8.1 (7.1-9.1) 68.5 (65.6-71.3) 5.3 (4.4-6.1) 9.6 (8.5-10.7) 3 (2.4-3.6) 
Ulsan 5.5 (4.6-6.5) 9 (7.8-10.2) 8.9 (7.7-10.1) 69.8 (66.6-72.9) 6.8 (5.7-7.8) 17.7 (16-19.3) 4.6 (3.8-5.5) 
Gyeongi 4.6 (4.3-4.9) 6 (5.6-6.3) 7.4 (7.1-7.7) 62.7 (61.7-63.7) 4.2 (4-4.5) 8.3 (7.9-8.7) 2.5 (2.3-2.7) 
Gangwon 9 (8-10.1) 7.3 (6.3-8.3) 9.5 (8.3-10.6) 63.6 (60.7-66.5) 5.8 (4.9-6.6) 9.7 (8.6-10.9) 2.9 (2.3-3.5) 
ChungBuk 9.9 (8.8-11) 10.5 (9.4-11.7) 11.4 (10.2-12.6) 65.9 (63.1-68.7) 7.4 (6.4-8.3) 11.7 (10.5-12.9) 4.9 (4.1-5.7) 
ChungNam 16.4 (15.2-17.6) 13.1 (12-14.3) 13.3 (12.2-14.4) 65.4 (63-67.8) 7.8 (7-8.7) 15.9 (14.7-17.1) 6.6 (5.8-7.4) 
JeonBuk 11.1 (10-12.1) 11.2 (10.1-12.2) 13.4 (12.2-14.6) 71.9 (69.2-74.6) 11 (10-12.1) 12.7 (11.6-13.8) 7.9 (7-8.8) 
JeonNam 15.9 (14.7-17.1) 13.3 (12.2-14.5) 15.6 (14.4-16.9) 51.9 (49.6-54.1) 4 (3.4-4.6) 8.7 (7.8-9.7) 4.3 (3.7-5) 
GyeonBuk 9.8 (9-10.7) 9.3 (8.5-10.1) 9.9 (9.1-10.8) 53.1 (51.1-55) 4.6 (4-5.1) 9.8 (9-10.7) 3 (2.5-3.5) 
GyeonNam 8.1 (7.4-8.8) 9.5 (8.8-10.2) 10.5 (9.7-11.3) 61.8 (59.9-63.7) 6 (5.4-6.6) 14.7 (13.8-15.7) 6.5 (5.9-7.1) 
Jeju 13 (10.9-15.1) 14.7 (12.5-16.9) 14.1 (11.8-16.3) 36.7 (33.1-40.3) 9.7 (7.8-11.5) 8.9 (7.2-10.7) 2.1 (1.2-2.9) 
Age-
Adjusted* 
Seoul 4 (3.7-4.3) 5.6 (5.3-5.9) 6.9 (6.5-7.3) 79.1 (77.7-80.5) 3.8 (3.5-4.2) 9.7 (9.2-10.3) 2.5 (2.2-2.7) 
Busan 4.4 (3.9-4.8) 7.5 (6.8-8.2) 6.9 (6.3-7.6) 74.3 (71.9-76.6) 6.1 (5.4-6.9) 17 (15.6-18.3) 6.7 (5.9-7.6) 
Daegu 4.2 (3.6-4.7) 4.6 (4.1-5.2) 5.3 (4.7-6) 68.2 (65.6-70.8) 4.3 (3.6-4.9) 11.4 (10.2-12.7) 4.1 (3.4-4.8) 
Incheon 6.3 (5.6-7) 6.1 (5.5-6.7) 6.6 (6-7.3) 79.6 (77-82.1) 3.2 (2.7-3.8) 9.3 (8.3-10.2) 2.5 (2-2.9) 
Gwangju 7.3 (6.3-8.3) 8.6 (7.5-9.7) 9.9 (8.7-11) 79 (75.6-82.4) 9.1 (7.9-10.3) 21.4 (19.4-23.4) 12.3 (10.8-13.7) 
Daejeon 6.7 (5.8-7.7) 8.9 (7.8-9.9) 7.5 (6.5-8.4) 84.8 (81.3-88.2) 6.2 (5.1-7.2) 14 (12.4-15.7) 4.3 (3.4-5.2) 
Ulsan 5.9 (4.8-6.9) 9.1 (7.8-10.3) 9.3 (8-10.6) 89.1 (85.1-93.1) 8.4 (7-9.8) 26.2 (23.7-28.7) 6.2 (5-7.4) 
Gyeongi 4.8 (4.5-5.1) 5.8 (5.5-6.1) 7.2 (6.8-7.5) 78.5 (77.3-79.7) 4.7 (4.4-5) 10.8 (10.3-11.3) 3 (2.8-3.3) 
Gangwon 6.8 (5.9-7.6) 5.7 (4.9-6.5) 7.4 (6.4-8.3) 83.5 (79.7-87.4) 7.2 (6-8.4) 16 (14-18) 3.7 (2.8-4.5) 
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ChungBuk 8.8 (7.7-9.9) 9.6 (8.5-10.7) 10.4 (9.2-11.5) 84.9 (81.3-88.5) 8.7 (7.5-9.9) 16.9 (15.1-18.7) 6.3 (5.2-7.4) 
ChungNam 12.4 (11.4-13.5) 10.9 (9.9-11.9) 11.6 (10.5-12.7) 83.7 (80.6-86.7) 9.4 (8.3-10.4) 24.1 (22.2-25.9) 8.6 (7.5-9.7) 
JeonBuk 11 (9.9-12.1) 11.5 (10.4-12.7) 14.8 (13.4-16.2) 92.8 (89.3-96.2) 15.5 (13.9-17.1) 17.5 (15.8-19.2) 11.3 (10-12.7) 
JeonNam 10.7 (9.8-11.6) 9.6 (8.8-10.5) 11.9 (10.9-13) 63.6 (60.7-66.5) 4.9 (4-5.7) 12.3 (10.8-13.7) 5.4 (4.4-6.3) 
GyeonBuk 7 (6.4-7.6) 7.5 (6.8-8.2) 7.9 (7.1-8.6) 70.6 (68-73.2) 5.7 (4.9-6.5) 14.9 (13.6-16.3) 4.2 (3.5-4.9) 
GyeonNam 6.9 (6.3-7.5) 8.6 (7.9-9.3) 9.8 (9-10.6) 77.7 (75.3-80) 7.1 (6.4-7.9) 21.7 (20.3-23) 8 (7.2-8.8) 




Table 2-7. Crude and Age-Adjusted Annual Incidence (per 1,000) of pneumonia and influenza in-patient in South Korea during 2006-2013 season by state level.   
  06-07 Season 07-08 Season 08-09 Season 09-10 Season 10-11 Season 11-12 Season 12-13 Season 
Crude 
Seoul 2.8 (2.6-3.1) 2.7 (2.5-2.9) 2.8 (2.6-3.1) 3.5 (3.3-3.8) 3.7 (3.5-4) 4.1 (3.8-4.4) 3.2 (3-3.5) 
Busan 5.2 (4.7-5.7) 5.1 (4.6-5.6) 4.3 (3.8-4.7) 6.8 (6.2-7.4) 7.3 (6.7-7.9) 10.3 (9.6-11) 7.6 (6.9-8.2) 
Daegu 3.5 (3-4.1) 4 (3.5-4.6) 3.7 (3.1-4.2) 5.9 (5.2-6.6) 5.8 (5.2-6.5) 8.2 (7.4-9) 5.6 (4.9-6.2) 
Incheon 2.8 (2.3-3.2) 2.6 (2.2-3) 2.6 (2.1-3) 4.5 (4-5.1) 5 (4.4-5.6) 6 (5.3-6.6) 4.3 (3.8-4.9) 
Gwangju 6.9 (6-7.9) 6.6 (5.6-7.5) 7.8 (6.8-8.8) 11.3 (10.1-12.5) 13.3 (12-14.7) 16.1 (14.7-17.5) 14.9 (13.5-16.2) 
Daejeon 3.8 (3.1-4.5) 4.2 (3.5-4.9) 3.6 (3-4.3) 4.9 (4.1-5.7) 4.5 (3.7-5.2) 6.2 (5.3-7.1) 6.4 (5.5-7.3) 
Ulsan 3.5 (2.7-4.2) 3.6 (2.9-4.4) 3.3 (2.6-4) 5.3 (4.4-6.2) 7 (5.9-8.1) 8.9 (7.7-10.1) 7.5 (6.4-8.6) 
Gyeongi 3.7 (3.4-3.9) 3.3 (3.1-3.5) 3.1 (2.9-3.3) 4.7 (4.4-5) 4.9 (4.6-5.2) 5.9 (5.6-6.2) 4.4 (4.1-4.6) 
Gangwon 4.2 (3.4-4.9) 4.3 (3.5-5) 4.1 (3.3-4.8) 6.3 (5.3-7.2) 6.9 (5.9-7.9) 9.7 (8.6-10.8) 6.7 (5.7-7.6) 
ChungBuk 3.2 (2.6-3.8) 3.4 (2.8-4.1) 5 (4.2-5.8) 6 (5.2-6.9) 8.3 (7.3-9.3) 11.6 (10.4-12.8) 9.4 (8.3-10.5) 
ChungNam 4.3 (3.7-4.9) 4.5 (3.8-5.1) 4.8 (4.2-5.5) 6 (5.2-6.7) 7.9 (7-8.7) 10.8 (9.8-11.8) 8.8 (7.8-9.7) 
JeonBuk 4.7 (4-5.4) 5.4 (4.7-6.2) 5.6 (4.8-6.3) 8 (7.1-8.9) 8.7 (7.7-9.6) 10.9 (9.9-12) 9.8 (8.8-10.8) 
JeonNam 8.1 (7.2-8.9) 9 (8.1-10) 8.8 (7.8-9.7) 14.4 (13.2-15.7) 14.3 (13.1-15.5) 18.4 (17.1-19.8) 16.5 (15.3-17.8) 
GyeonBuk 4.7 (4.1-5.2) 3.6 (3.1-4.1) 4.7 (4.1-5.2) 6.8 (6-7.5) 7.9 (7.1-8.6) 10.5 (9.7-11.4) 7.4 (6.7-8.1) 
GyeonNam 8.1 (7.4-8.8) 7.9 (7.2-8.6) 9.2 (8.5-10) 12 (11.2-12.9) 12.7 (11.9-13.6) 16.8 (15.9-17.8) 14.3 (13.4-15.2) 
Jeju 5.6 (4.3-7) 7.1 (5.6-8.7) 4.4 (3.2-5.7) 6.3 (4.8-7.8) 10.2 (8.3-12.1) 9.2 (7.4-11) 8.2 (6.5-9.9) 
Age-
Adjusted* 
Seoul 4.8 (4.4-5.2) 4.1 (3.7-4.5) 4.2 (3.8-4.6) 5.5 (5-5.9) 5.9 (5.4-6.3) 6.1 (5.7-6.6) 4.3 (4-4.7) 
Busan 10.4 (9.3-11.4) 9.4 (8.4-10.4) 7.5 (6.6-8.4) 11.4 (10.3-12.5) 12.9 (11.8-14.1) 18 (16.7-19.4) 12.7 (11.5-13.8) 
Daegu 5.9 (5.1-6.8) 6.7 (5.7-7.6) 6.1 (5.2-7.1) 9.7 (8.6-10.9) 9.2 (8.1-10.3) 12.6 (11.3-13.9) 8.5 (7.5-9.6) 
Incheon 4.2 (3.4-4.9) 3.7 (3-4.3) 3.5 (2.9-4.1) 6.5 (5.7-7.4) 7.1 (6.3-8) 8.3 (7.4-9.2) 5.3 (4.6-6) 
Gwangju 10 (8.7-11.4) 9.6 (8.2-11) 12 (10.4-13.6) 18.2 (16.3-20.1) 20.3 (18.4-22.2) 24.7 (22.7-26.8) 21.7 (19.8-23.7) 
Daejeon 5.2 (4.2-6.2) 5.7 (4.7-6.7) 4.8 (3.9-5.8) 7 (5.8-8.1) 6 (4.9-7.1) 8.2 (7-9.5) 9.1 (7.8-10.4) 
Ulsan 5.1 (4-6.3) 4.8 (3.8-5.9) 4.6 (3.6-5.7) 7.1 (5.8-8.4) 10.1 (8.5-11.7) 13 (11.2-14.8) 11.2 (9.6-12.9) 
Gyeongi 5.2 (4.8-5.5) 4.4 (4.1-4.7) 4.2 (3.9-4.5) 6.6 (6.2-7) 6.7 (6.3-7.1) 7.9 (7.4-8.3) 5.4 (5.1-5.8) 
Gangwon 5.7 (4.6-6.8) 5.7 (4.6-6.8) 5.4 (4.3-6.6) 9.3 (7.8-10.9) 8.2 (6.8-9.6) 12.8 (11.1-14.6) 7.8 (6.5-9.2) 
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ChungBuk 4.5 (3.5-5.5) 4.5 (3.6-5.4) 6.5 (5.4-7.6) 8.5 (7.2-9.9) 11.7 (10.2-13.2) 15.9 (14.1-17.6) 11.2 (9.8-12.6) 
ChungNam 5 (4.2-5.9) 5.6 (4.7-6.5) 6 (5.1-7) 7.9 (6.8-8.9) 9.3 (8.2-10.5) 13 (11.7-14.3) 9.3 (8.2-10.4) 
JeonBuk 5.5 (4.6-6.4) 6.7 (5.7-7.7) 7.1 (6-8.1) 11.2 (9.8-12.6) 10.8 (9.5-12.2) 12.8 (11.4-14.2) 10.7 (9.4-12) 
JeonNam 12.2 (10.8-13.6) 13.4 (11.9-14.9) 13.1 (11.6-14.6) 22.2 (20.3-24.1) 21.2 (19.3-23.1) 25.1 (23.1-27.1) 22.2 (20.3-24.1) 
GyeonBuk 7.1 (6.1-8) 5.4 (4.6-6.2) 6.7 (5.8-7.7) 10.2 (9.1-11.3) 10.5 (9.4-11.6) 12.8 (11.6-14) 8.8 (7.8-9.8) 
GyeonNam 12.4 (11.3-13.4) 11.8 (10.8-12.8) 13.8 (12.6-14.9) 18.1 (16.8-19.4) 18.4 (17.1-19.7) 23.6 (22.2-25) 19.6 (18.3-20.9) 





Table 2-8. Crude and Age-Adjusted Annual Incidence (per 1,000) of severe acute respiratory illness in South Korea during 2006-2013 season by state level.   
  06-07 Season 07-08 Season 08-09 Season 09-10 Season 10-11 Season 11-12 Season 12-13 Season 
Crude 
Seoul 3.4 (3.2-3.7) 3.3 (3-3.5) 3.5 (3.2-3.7) 4.3 (4-4.6) 4.3 (4.1-4.6) 4.9 (4.6-5.2) 4 (3.8-4.3) 
Busan 6.7 (6.1-7.3) 6.9 (6.3-7.5) 6.1 (5.6-6.7) 9.3 (8.6-10) 10.4 (9.7-11.1) 13.6 (12.7-14.4) 10.4 (9.7-11.2) 
Daegu 4.1 (3.5-4.6) 5 (4.4-5.7) 4.7 (4.1-5.3) 6.9 (6.1-7.6) 6.9 (6.1-7.6) 9.7 (8.9-10.6) 7 (6.3-7.8) 
Incheon 3.5 (3-4) 3.1 (2.7-3.6) 3.4 (2.9-3.9) 5.4 (4.8-6) 6 (5.3-6.6) 6.8 (6.1-7.4) 5.2 (4.6-5.8) 
Gwangju 8.6 (7.5-9.7) 8.5 (7.4-9.5) 10.1 (8.9-11.2) 14.4 (13-15.8) 16.2 (14.8-17.6) 19.8 (18.2-21.4) 18.5 (17-20) 
Daejeon 4.5 (3.8-5.3) 4.7 (3.9-5.5) 4.3 (3.6-5) 5.5 (4.7-6.4) 5.4 (4.6-6.3) 6.8 (5.9-7.7) 7.1 (6.1-8) 
Ulsan 4.3 (3.5-5.2) 4.4 (3.6-5.2) 4.2 (3.4-5) 6.7 (5.7-7.7) 7.9 (6.7-9) 10.9 (9.6-12.2) 9.5 (8.2-10.7) 
Gyeongi 4.4 (4.2-4.7) 4.1 (3.9-4.4) 4.2 (3.9-4.4) 5.7 (5.4-6) 5.8 (5.5-6.1) 7 (6.7-7.3) 5.5 (5.2-5.8) 
Gangwon 4.9 (4.1-5.7) 5.1 (4.3-5.9) 5.1 (4.2-5.9) 7.7 (6.7-8.8) 8.2 (7.2-9.3) 11 (9.8-12.2) 8.7 (7.6-9.8) 
ChungBuk 3.8 (3.1-4.5) 4.1 (3.4-4.8) 5.8 (5-6.7) 7.1 (6.2-8.1) 9.7 (8.6-10.8) 13.1 (11.8-14.4) 10.8 (9.6-11.9) 
ChungNam 5.3 (4.6-6) 5.4 (4.7-6.1) 5.8 (5.1-6.6) 7.2 (6.4-8.1) 9.4 (8.5-10.4) 12.7 (11.7-13.8) 10.2 (9.2-11.2) 
JeonBuk 5.9 (5.1-6.6) 6.9 (6.1-7.7) 7.1 (6.2-8) 10.1 (9-11.1) 10.8 (9.8-11.9) 13.7 (12.5-14.9) 12.7 (11.5-13.8) 
JeonNam 9.9 (8.9-10.8) 12.2 (11.1-13.3) 13 (11.8-14.1) 19.8 (18.4-21.3) 19.1 (17.7-20.4) 25.1 (23.6-26.7) 22.6 (21.1-24.1) 
GyeonBuk 5.4 (4.8-6) 4.6 (4.1-5.2) 6.1 (5.4-6.8) 8.2 (7.4-9) 9.8 (8.9-10.6) 12.6 (11.6-13.5) 9.8 (9-10.6) 
GyeonNam 9.9 (9.1-10.7) 10.2 (9.4-11) 11.9 (11.1-12.8) 15.2 (14.2-16.1) 15.7 (14.8-16.7) 20.1 (19.1-21.2) 17.6 (16.6-18.6) 
Jeju 6.2 (4.8-7.7) 8.9 (7.1-10.6) 5.7 (4.3-7.2) 8 (6.3-9.7) 11.7 (9.7-13.7) 11 (9.1-12.9) 10.4 (8.5-12.3) 
Age-
Adjusted* 
Seoul 6 (5.6-6.5) 5.2 (4.8-5.6) 5.3 (4.9-5.7) 6.9 (6.4-7.4) 7 (6.5-7.5) 7.5 (7-8) 5.8 (5.4-6.2) 
Busan 13.5 (12.3-14.7) 13.1 (11.9-14.2) 11.3 (10.2-12.3) 16.5 (15.2-17.8) 19.4 (17.9-20.8) 24.6 (23-26.1) 18.4 (17.1-19.8) 
Daegu 6.9 (6-7.9) 8.3 (7.3-9.4) 7.9 (6.8-8.9) 11.4 (10.1-12.6) 11 (9.8-12.2) 15.1 (13.7-16.5) 11.2 (10-12.4) 
Incheon 5.2 (4.4-6) 4.5 (3.8-5.2) 4.9 (4.2-5.6) 8.1 (7.2-9.1) 8.7 (7.7-9.7) 9.5 (8.5-10.5) 6.7 (5.9-7.5) 
Gwangju 12.6 (11-14.1) 12.6 (11-14.1) 15.3 (13.5-17) 23.4 (21.3-25.5) 24.4 (22.3-26.5) 29.9 (27.7-32.2) 27 (24.9-29.1) 
Daejeon 6.3 (5.2-7.4) 6.5 (5.4-7.6) 6 (4.9-7) 8 (6.8-9.3) 7.8 (6.5-9) 9.3 (8-10.6) 10.1 (8.7-11.5) 
Ulsan 6.5 (5.2-7.8) 6 (4.8-7.2) 5.9 (4.7-7.1) 9.3 (7.9-10.8) 11.5 (9.8-13.2) 16.3 (14.4-18.3) 14.3 (12.4-16.1) 
Gyeongi 6.4 (6-6.8) 5.6 (5.3-6) 5.7 (5.3-6) 8.1 (7.7-8.5) 8 (7.5-8.4) 9.5 (9-9.9) 7.1 (6.7-7.5) 
Gangwon 6.8 (5.6-8) 7.1 (5.9-8.4) 7 (5.7-8.3) 12.2 (10.4-13.9) 10.2 (8.7-11.8) 14.5 (12.7-16.4) 10.5 (8.9-12) 
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ChungBuk 5.5 (4.4-6.6) 5.4 (4.4-6.5) 7.9 (6.6-9.2) 10.4 (8.9-11.9) 13.9 (12.2-15.5) 18.1 (16.2-19.9) 13.2 (11.7-14.7) 
ChungNam 6.5 (5.6-7.5) 7 (6-8) 7.4 (6.4-8.4) 9.7 (8.5-10.8) 11.3 (10.1-12.6) 15.3 (13.9-16.7) 11.3 (10.1-12.5) 
JeonBuk 7.2 (6.2-8.3) 8.7 (7.5-9.8) 9.4 (8.1-10.6) 14 (12.4-15.5) 14.1 (12.6-15.6) 16.5 (14.9-18.1) 14.4 (12.9-15.9) 
JeonNam 14.8 (13.3-16.4) 18.1 (16.4-19.7) 19.3 (17.6-21.1) 30.9 (28.7-33.1) 28.6 (26.4-30.7) 35.4 (33.1-37.7) 31.3 (29.1-33.4) 
GyeonBuk 8.4 (7.4-9.5) 7.2 (6.2-8.1) 9.1 (8-10.1) 12.6 (11.3-13.8) 13.6 (12.3-14.8) 15.8 (14.4-17.1) 12.7 (11.5-13.9) 
GyeonNam 15.2 (14.1-16.4) 15.2 (14-16.3) 17.8 (16.5-19) 22.9 (21.5-24.3) 22.7 (21.3-24.1) 28.3 (26.7-29.8) 24.2 (22.8-25.6) 





Table 2-9. Crude and age-Adjusted recent 3 years Average Annual Incidence*(per 1,000) of seasonal influenza out-patient, pneumonia and influenza in-patient, and severe 
acute respiratory illness in South Korea during 2010-2012 season by state level.  
 
Influenza Out-Patient Pneumonia and Influenza In-patient Severe Acute Respiratory Illness 
 
Crude Adjusted Crude Adjusted Crude Adjusted 
Seoul 3.9 (3.8-4.1) 5.3 (5.1-5.6) 3.7 (3.5-3.8) 5.4 (5.2-5.7) 4.4 (4.3-4.6) 6.8 (6.5-7) 
Busan 6.2 (5.9-6.5) 9.9 (9.3-10.5) 8.4 (8-8.8) 14.6 (13.8-15.3) 11.5 (11-11.9) 20.8 (20-21.6) 
Daegu 4.6 (4.3-5) 6.6 (6.1-7.1) 6.6 (6.1-7) 10.1 (9.5-10.8) 7.9 (7.4-8.3) 12.5 (11.7-13.2) 
Incheon 3.9 (3.6-4.2) 5 (4.6-5.4) 5.1 (4.8-5.4) 6.9 (6.5-7.4) 6 (5.6-6.3) 8.3 (7.8-8.9) 
Gwangju 11.1 (10.4-11.8) 14.3 (13.3-15.2) 14.8 (14-15.6) 22.3 (21.1-23.4) 18.2 (17.3-19.1) 27.1 (25.9-28.4) 
Daejeon 6 (5.5-6.5) 8.2 (7.5-8.9) 5.7 (5.2-6.2) 7.8 (7.1-8.5) 6.4 (5.9-7) 9.1 (8.3-9.8) 
Ulsan 9.7 (9-10.4) 13.5 (12.5-14.6) 7.8 (7.1-8.4) 11.5 (10.5-12.4) 9.4 (8.7-10.1) 14.1 (13-15.1) 
Gyeongi 5 (4.8-5.2) 6.2 (6-6.4) 5 (4.9-5.2) 6.7 (6.4-6.9) 6.1 (5.9-6.3) 8.2 (7.9-8.4) 
Gangwon 6.1 (5.6-6.7) 9 (8.1-9.8) 7.8 (7.2-8.3) 9.6 (8.7-10.5) 9.3 (8.7-10) 11.7 (10.8-12.7) 
ChungBuk 8 (7.4-8.6) 10.6 (9.8-11.5) 9.8 (9.1-10.4) 12.9 (12-13.8) 11.2 (10.5-11.9) 15 (14.1-16) 
ChungNam 10.1 (9.6-10.7) 14.1 (13.3-14.9) 9.2 (8.6-9.7) 10.6 (9.9-11.3) 10.8 (10.2-11.4) 12.7 (11.9-13.4) 
JeonBuk 10.6 (9.9-11.2) 14.8 (13.9-15.7) 9.8 (9.2-10.4) 11.4 (10.7-12.2) 12.4 (11.7-13) 15 (14.1-15.9) 
JeonNam 5.7 (5.3-6.1) 7.5 (6.9-8.1) 16.4 (15.7-17.2) 22.8 (21.7-24) 22.3 (21.4-23.1) 31.8 (30.5-33.1) 
GyeonBuk 5.8 (5.4-6.2) 8.3 (7.7-8.9) 8.6 (8.2-9.1) 10.7 (10.1-11.3) 10.7 (10.2-11.2) 14 (13.3-14.7) 
GyeonNam 9.1 (8.7-9.5) 12.2 (11.6-12.8) 14.6 (14.1-15.2) 20.6 (19.8-21.3) 17.8 (17.2-18.4) 25.1 (24.3-25.9) 





Table 2-10. Incidence ratio comparison between case definitions and extended case definition 
















patient/ influenza  
out-patient ratio 
Age under 5 2.00 1.50 1.44 1.23 1.37 1.28 1.29 
Age 5-15 1.61 1.51 1.42 1.15 1.32 1.23 1.34 
Age 16-50 1.33 1.30 1.30 1.13 1.29 1.26 1.23 
Age 51-65 1.19 1.21 1.15 1.17 1.31 1.28 1.23 
Age over 65 1.14 1.11 1.07 1.12 1.26 1.25 1.31 








Age under 5 1.28 1.28 1.26 1.27 1.18 1.19 1.20 
Age 5-15 1.24 1.34 1.29 1.16 1.14 1.13 1.19 
Age 16-50 1.39 1.37 1.37 1.30 1.22 1.20 1.29 
Age 51-65 1.64 1.53 1.54 1.50 1.45 1.40 1.38 
Age over 65 1.76 1.60 1.57 1.50 1.50 1.41 1.43 
Total  1.40 1.39 1.38 1.32 1.29 1.26 1.30 
Extended SARI / 
SARI ratio  
Age under 5 1.33 1.38 1.37 1.33 1.30 1.27 1.32 
Age 5-15 1.33 1.50 1.50 1.24 1.24 1.22 1.45 
Age 16-50 1.47 1.44 1.44 1.36 1.37 1.30 1.41 
Age 51-65 1.63 1.57 1.58 1.50 1.50 1.45 1.43 
Age over 65 1.77 1.62 1.58 1.55 1.52 1.43 1.45 




Table 2-11. Incidence Ratio comparison for influenza out-patient diagnosis pattern change  


















Age under 5 0.12 0.10 0.10 0.04 0.13 0.15 0.27 
Age 5-15 0.01 0.04 0.06 0.02 0.07 0.09 0.16 
Age 16-50 0.01 0.01 0.02 0.01 0.07 0.06 0.11 
Age 51-65 0.00 0.01 0.01 0.03 0.07 0.08 0.14 
Age over 65 0.00 0.00 0.00 0.03 0.06 0.14 0.19 
Total  0.01 0.01 0.02 0.02 0.08 0.10 0.16 
influenza out-
patient ratio / 
pneumonia 
and influenza  
out-patient 
Age under 5 0.02 0.03 0.04 0.42 0.05 0.15 0.06 
Age 5-15 0.07 0.10 0.14 0.78 0.15 0.28 0.16 
Age 16-50 0.26 0.26 0.29 0.81 0.25 0.25 0.18 
Age 51-65 0.36 0.34 0.37 0.54 0.16 0.17 0.09 
Age over 65 0.51 0.48 0.51 0.45 0.09 0.11 0.06 





Chapter 3 : The use of medical billing information in influenza temporal 
trends monitoring system: timeliness validation on a new source of 





Objective To validate the use of billing system as an alternative influenza surveillance data source 
and compare the timeliness of the epidemiological information from billing system to the current 
influenza surveillance system in South Korea.   
Participants 1,021,576 individuals randomly selected from the national health insurance in Korea. 
Followed from the 36th week of 2010 to 35th week of 2013.  
Methods Used 6 different case definitions to define influenza activity (3 base case definition and 3 
extended). Compared the timeliness of influenza activity captured by those case definitions in billing 
information. Applied peak time comparison, aberration time comparison, and time-series correlation 
function to quantify the timeliness.  
Results For peak time comparison, ‘Influenza outpatient’ case definition showed average 0-week 
time difference compared to the current surveillance system. ‘Pneumonia and influenza inpatient (PNI-
ADM)’ and ‘Severe acute respiratory illness (SARI)’ case definitions showed 1-week late time difference. 
For time-series correlation, ‘Influenza outpatient’ showed average 0.33 week earlier activity with 
average maximum cross-correlation value 0.97, while ‘PNI-ADM’ and ‘SARI’ showed 0.67 and 0 week 
time difference with average maximum cross-correlation 0.75 and 0.75. For aberration time comparison, 
each case definition showed an average 1.33, 0.67, and 2.33 week late signals in high sensitivity setting 
compared to the current system. In high specificity setting, only ‘Influenza outpatient’ was able to 
generate signals among various case definitions and it was 0.33 week early in average compared to the 
current system.  
Conclusions We could not see any epidemiologically significant differences between the proposed 
source and current influenza surveillance system. These findings suggested that we may use billing 
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information as a surrogate of seasonal influenza activity. Moreover, a million of individuals in new data 
source will be beneficial to provide more granular influenza activity information through age and 
geographical stratification.  
Introduction  
The term influenza originated from Italian, originally from the Latin ‘influential’, reflecting 
the effect of stars on disease epidemic1. As it is shown its name, influenza has shown a 
tremendous seasonal pattern with two distinctive characteristics in a temperate climate2,3. 
First, it starts its high activity when the temperature is getting low in temperate climate region, 
which means winter is the beginning time of high seasonal activity at each hemisphere. Second, 
the actual rise of influenza activities is varied on every year, so we cannot expect the specific 
time of on set in high seasonal activity.  
Monitoring influenza’s temporal pattern is not only critical for disease control and 
prevention and but also essential for pandemic influenza preparedness. Monitoring temporal 
trends can be explained two different approaches: Observing early aberration signals at the 
beginning of the high seasonal activity and detecting outnumbered events during the high 
seasonal activity. Identifying aberration will lead us to prepare hospital infection control action 
strategy and early initiation of influenza treatment to reduce the hospital/community 
transmission4,5. Moreover, capturing unexpected seasonal activity in temporal trends may give 
us insight for a pandemic influenza movement6.  
In South Korea, one of the current influenza surveillance systems is outpatient influenza 
activity monitoring based on 200 sentinels, conveniently selected, with a proportion of 
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influenza-like-illness patient7–9. This surveillance approach provides the temporal trends 
changes over time with a proportion of influenza-like-illness based on total outpatients’ medical 
visits at the national level. However, the intensity of influenza in the current system is a relative 
measured, as a proportion, which we cannot estimate actual intensity as absolute disease 
burden. Lack of representativeness and sample size are one of the reasons why this surveillance 
system could not provide any sub-group information for influenza activity. Moreover, in the 
World Health Organization influenza surveillance monitoring guideline, it suggested that 
countries should focus on not only influenza outpatient, but also other serious cases such as 
pneumonia and influenza admission or severe acute respiratory illness (SARI)10,11.  
There have been some studies on the use of insurance billing information as a direct 
measure of influenza activity12–15. In their approach used combinations of the international 
classification of disease code (ICD10) to define different case definitions of seasonal influenza. 
However, those new approaches are not applied to South Korea yet.  
Therefore, we proposed the use of billing information and its diagnosis codes as an 
alternative source of influenza surveillance especially in temporal tends monitoring. We verified 
our proposed approach with three different timeliness comparison methods to current 
influenza surveillance. Since South Korea has a universal single-payer health insurance system 
and all of the information was databased for research purpose, the use of this information 
could be beneficial to support current influenza surveillance. Moreover, approximately a million 





In this study, we analyzed the information from the National Health Information Databases 
(NHID) from the National Health Insurance Service. South Korea provides universal-single payer 
insurance system to cover most of the Korean population16. NHID contains most of the Korean 
residents’ information on medical treatments records with individual characteristics. To use this 
information for surveillance purpose, we focused on ‘detailed of disease section’ from ‘medical 
treatment’ database and ‘insurance eligibility’ database. We merged individuals’ characteristics, 
such as age, location, to diagnosis codes in billing information which contained in ‘detailed of 
disease section.’ In billing information, we integrated date of medical procedure, medical 
procedure type (outpatient/inpatient), diagnosis codes (based on the Korean Classification 
Diseases 5 & 6, KCD 5 & 6)17, and doctors’ specialty information (internal medicine, emergency 
department, etc.).  
To remove the confidentiality issues with individual matching information, we performed 
stratified random selection based on geographical location and age group. Even though we 
reduce our sample size, we still maintained the representativeness of our samples with enough 
number of individuals in one million individual’s observation (2% of the entire population). The 
total study period was defined from 36th week of 2010 to 35th week of 2013, and a total 
number of participants in this study was total 1,021,576 individuals based on time period. Each 
influenza season was defined from current years’ 36th week to next years’ 35th week to 
account the seasonality of influenza. 
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There were two exclusion criteria in this study. First, we excluded multiple medical visits 
with the same diagnostic codes. In billing information, there are a certain amount of multiple 
medical visits in a short amount of time with the same disease diagnosis codes.  (For example, 
age 3 toddler visited pediatrics 4 times during a month with Influenza due to unidentified 
influenza virus with other respiratory manifestations (J11.1)). In this case, we considered these 
multiple events are due to single disease episode. We excluded other medical visits which 
followed from first medical visits with the same diagnosis code within 28 days. Second, we 
excluded billing information from the institutions where do not focus on primary care. There 
were some billing information contains other respiratory illness from non-primary care 
departments such as orthopedics or general surgeon departments. Since those specialties are 
not primarily deal with acute respiratory illness, we decided that that information is not 
relevant to monitor temporal trends of seasonal influenza. Thus, we excluded billing 
information from non-primary care department, only counted information from a general 
physician, internal medicine, family medicine, pediatrics, emergency department, and 
otolaryngology. 
To capture various clinical patterns of seasonal influenza, we used the International 
Statistical Classification of Diseases and Related Health Problems (ICD) and outpatient/inpatient 
status to define 3 different base case definitions. First, Influenza outpatient (FLU-OPD). This 
case definition followed individuals who visit the outpatient clinical setting with a confirmatory 
diagnosis of influenza. Therefore, we defined influenza outpatient as individuals who visited an 
outpatient facility with a primary diagnosis code with influenza illness (J09, J10, and J11) in their 
primary billing information13,18.  Second, Pneumonia and influenza in-patients (PNI-ADM). This 
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definition is corresponding with admitted individuals due to pneumonia and influenza19,20. To 
capture those individuals, we looked up primary diagnosis with influenza and pneumonia (J12-
J18) codes in their billing information. Third, severe acute respiratory illness (SARI). This case 
definition includes admitted other acute lower respiratory illness on top of pneumonia and 
influenza. We extended our case definition from influenza and pneumonia to other acute lower 
respiratory illness (J20-22) in primary diagnosis code in admitted patients12,14. We also extended 
our case definition from primary only to primary and secondary diagnosis code, to increase the 
sensitivity of those definitions.  
There has been the use of different metrics to validate the timeliness of two different 
surveillance sources. In this study we followed the three most common timeliness validation 
approaches to quantify temporal difference; peak time comparison, cross-correlation, and 
aberration time comparison21–28.  
In peak time comparison, we calculated the weekly proportion of influenza-like-illness or 
weekly incidence of case definitions and chose the epidemiological week with the highest value 
in each surveillance year. Then we determined the time difference between proposed and 
reference surveillance source. For cross-correlation, we transformed each source’s 
epidemiological curve into a time-series format then computed time lags to the maximum 
correlation. We considered the time lag with the value of the greatest number as the time 
variation.  
At the aberration time comparison, we applied the Early Aberration Reporting System 
(EARS)’s signal detection algorithms, developed by the United States Centers for Disease 
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Control and Preventions, to generate the signals at the beginning of the high seasonal 
activity29,30. We ran different EARS’s algorithms, C1, C2 and C3 with various thresholds and 
signal counting approaches to acquire highly sensitive model and highly specified model. To 
generate the signals from any suspected aberration activities and gain the signals as early 
possible, we modified the EARS model to have high sensitivity. In high sensitivity model, we 
defined the first signal from the C3 algorithm in surveillance year an aberration signal. To 
reduce false positive and produce the only effective signal from relevant activity, we adjusted 
the EARS model to have a high specificity. In high specificity model, we determined the first two 
consecutive signals from C1 algorithm within surveillance year as an aberration signal. 
We noted the epidemiological week with the first week of aberration signal from reference 
and each case definition. Again, we examined the time difference between the reference ad 
proposed surveillance source. 
 
Results 
We followed up total 1,021,576 individuals for 156 weeks, from the 36th week of the year 
2010 to 35th week of the year 2013. The minimum value of the proportion of influenza-like-
illness patient from South Korea sentinel influenza surveillance system were 1.6, 1.5 and 1.6 
percentages in season 2010, 2011, and 2012 and the maximum proportion were 23.9, 23.1 and 
12.7. The lowest weekly incidence of influenza out-patient were 0.9, 0.3 and 0.3 cases per 
100,000 individuals from NHIS-NSC respectively, and the highest weekly incidence of influenza 
out-patient were 84.7, 87.4 and 39.7 cases per 100,000 individuals. The lowest weekly 
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incidence of pneumonia and influenza in-patient were 5.59, 7.55 and 6.23 cases per 100,000 
individuals and the highest weekly incidence were 26.05, 25.83, and 22.5 cases per 100,000 
individuals. For SARI, the lowest weekly incidence was 8.2, 9.3 and 8.9 cases per 100,000 
individuals and the highest were 32.9, 30.1 and 27.8 cases per 100,000 individuals respectively. 
The relative proportion from the lowest week to highest week at each surveillance year were 
14.9, 15,4 and 7.9 for influenza-like-illness. For relative incidence at each surveillance year were 
94.3, 292.0 and 133.7 for influenza out-patients, 4.7, 3.4 and 3.6 for PNI-ADM and 4.0, 3.2, and 
3.1 for SARI. (Figure 3-1) 
The peak week from proportion of influenza-like-illness and weekly incidence of FLU-OPD, 
PNI-ADM, and SARI with base and extended case definition ranged from 52th week of 2010 to 
1st week of 2011 for 2010 season, from 6th week of 2012 to 8th week of 2012 for 2011 season, 
and from 8th week of 2013 to 9th week of to 2012 season. The time difference between 
current influenza surveillance to proposed surveillance approach with each case definitions was 
one week early (season 2012 with influenza outpatient base and extended case definitions) to 2 
weeks late (season 2011 with PNI-ADM and SARI base case definition only). The recent 3 years 
average time difference were 1 week late with PNI-ADMI and SARI case definition and 0 for 
other case definitions. (Table 3-1 and Table 3-2.) 
The highest maximum cross-correlation value by reference and each case definition was 
0.986 at 2012 season with extended influenza out-patients case definition. The lowest 
maximum cross-correlation value was 0.666 at 2010 season with extended pneumonia and 
influenza inpatient. The recent 3 years average maximum cross-correlation values from each 
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case definitions were 0.974 and 0.976 for influenza outpatient base and extended case 
definitions. For PNI-ADM and SARI, the 3 years average maximum cross-correlation values were 
0.748 and 0.755 for base case definition and 0.748 and 0.758 for extended case definitions.  
(Table 3-3 and Table 3-4.) 
The time lag in maximum cross-correlation value ranged one week early (-1 week) to 2 
weeks later (+2 week). The recent 3 years average maximum cross-correlation value were -0.33 
for influenza out-patients base and extended case definitions and 0.67 for PNI-ADM base and 
extended case definitions and SARI extended case definition. And 0 for SARI base case 
definition.  
The first week of aberration signal with high sensitivity setting was 37th week to 41st week 
of 2010 for 2010 season, 36th week to 38th week of 2011 for 2011 season, and 37th to 44th 
week of 2012 for 2012 season. The recent 3 years average time different by the first week of 
aberration signal with high sensitivity setting were 1.33, 0.67 and 2.33 weeks for FLU-OPD, PNI-
ADM, and SARI with base case definition and 0.00, 3.00 and 3.33 weeks with extended case 
definition. (Table 3-5, Table 3-6, and Figure 3-2)  
The first week of aberration signal with high specificity setting was 49th week to 50th week 
of 2010 for 2010 season, 1st week of 2012 and 2013 for 2011 and 2012 season. We could not 
detect any aberration signals in PNI-ADM and SARI case definitions with high specificity setting. 
Influenza out-patients base and extended case definitions generate signals 1 week earlier (-1 
week) than reference source at season 2010 only. At season 2011 and 2012, the reference 
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source and influenza out-outpatients case definitions generated the signals at the same week.  
(Table 3-7, Table 3-8, and Figure 3-2)  
Discussion 
In this paper, we compared the timeliness of newly proposed surveillance source, billing 
information from the national health insurance system. We used three different timeliness 
validation approaches and did not observe any significant delays of influenza activities in peak 
time and cross-correlation methods. There were some delays of signals or no signals in 
aberration time comparison with different sensitivity specificity setting which led us more 
discussions on the use of aberration time comparison in timeliness validation approaches.  
Weekly incidence of influenza out-patients reflected actual fluctuation of disease dynamics 
and showed the exact ratio of disease intensity by time. The unit of influenza-like-illness is 
proportion, which means the number of influenza-like-illness patients divided by the total 
number of outpatients in a week. Since it is a proportion, the epidemiological curves from this 
case definition could not show actual disease intensity31,32. Sometimes the intensity of the 
disease, which is the high number of ILI patients, were diluted due to a large number of 
denominators in proportion calculation. For example, the proportion of influenza-like-illness 
can be smaller due to a sheer number of other events in denominator due to chronic disease in 
a specific age group. However, weekly incidence calculated from NHIS-NSC provided a direct 
disease trend from the sampled population. This implied that the epidemiological curves from 
billing information are a more accurate measure. Moreover, the proportion ratio of influenza-
like-illness from the lowest week to the largest weeks were 7.9 to 15.4 compared to 94.3 to 
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292.0. Therefore, we may interpret that the actual disease intensity changes were larger in 
influenza out-patients than the changes measured by sentinel surveillance.  
We did not find a lack of timeliness in temporal trends from influenza out-patients case 
definitions compared to the temporal trends from current sentinel surveillance in peak time 
and cross-correlation comparison methods. Base and extended influenza out-patients case 
definitions showed a week early to a week later temporal trends by influenza season year in the 
two methods. Moreover, the maximum correlation values are higher than 95% all the time. We 
may conclude that the use of influenza out-patients will give the same temporal trends in 
perspectives of peak time and cross-correlation functions compared to the current sentinel 
surveillance.  
While the epidemiological curve from PNI-ADM and SARI incidence followed little delayed in 
timeliness compared to the influenza-like-illness. In peak time comparison, base case 
definitions showed zero to two weeks the temporal trends each year. The natural history of 
influenza normally started with influenza-related symptoms, out-patients medical visited, then 
admitted due to severe cases33. The one to two weeks of delays in peak time is not because of 
lack of timeliness, is more likely due to the natural history of the disease itself. The value of 3 
years average maximum cross-correlation was lower than the values from influenza out-
patients. PNI-ADM and SARI showed higher weekly incidence than influenza out-patients in 
non-influenza peak season. Those observations indicated that there are also other factors in 
temporal trends in pneumonia and influenza in-patients and SARI than influenza infection only.  
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We observed signals in September with significant time delays aberrational time 
comparison, especially in high sensitivity setting. There were little increased of influenza activity 
at the beginning of September, and the lowest incidences were observed during the summer, 
July and August. Based on lower incidence for reference week in signal detection algorithms 
and a small amount of increased after school openings with high sensitivity model setting 
resulted generated the signals in September34,35. However, those signals were not directly 
related to the actual aberration in December and January. Therefore, we consider those signals 
as false positive. In high specificity setting, we could not observe the signals from PNI-ADM and 
SARI case definitions. Since PNI-ADM and SARI temporal trends did not show typical annual 
attends in epidemiological curves, the specificity model could not generate the signals.  
As stated from other literature aberration comparison is not an optimal approach to 
compare the timeliness of two different sources21. It really depends on the model, model’s 
direction (sensitivity and specificity) and priors, reference observations to build the signal 
detection algorithm in the model, based on previous outbreak information30. Aberration time is 
more depends on model selection process rather than actual timeliness of surveillance source 
and can be different by optimization of the signal detection algorithm.  
There are 3 public health implication points based on this study. The epidemiological curve 
from the use of billing information can give a direct disease intensity as weekly incidence which 
will not be affected by other disease incidences, which easily can be observed in the proportion 
of influenza-like-illness setting. Public health professionals can estimate the actual number of 
patients in high activity season and set up a health emergency plan more precisely. Moreover, 
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about a million individuals in the sampled cohort could provide stratified information for 
further detailed surveillance.  
Importantly, we did not observe any significant time delays especially influenza out-patients 
activity compared to the current sentinel observations in peak time, and cross-correlation 
function approaches. We will observe the same peak and almost the same patterns of 
epidemiological curves in the proposed approach. Furthermore, there has been a use of 
electronic real-time ‘drug utilized review (DUR)’ service in drug overuse surveillance in South 
Korea, there is a possibility to develop a real-time influenza surveillance system with the same 
approach.  
Lastly, this approach could provide other influenza-related diseases such as Pneumonia and 
Influenza inpatient and Severe Acute Respiratory Illness. Current influenza surveillance system 
provides a proportion of influenza-like-illness, percentage of the influenza-positive rate from 
specimens and the strains of positive specimens. Providing temporal trends of severe influenza 
cases can be beneficial to understand the natural history of influenza in South Korea, moreover 
to set up a projection of future public health preparedness for influenza-related admissions.  
However, few more things need to addressed. Current comparison is only based on 3 years 
observation after the pandemic season. 3 years of observation may not be enough to make a 
strong conclusion of the new approach to influenza surveillance. Including more years with 




Moreover, those approaches are based on a retrospective study. Even though we did not 
observe any delays in two timeliness comparison approach, those are based on data which are 
already collected. When we apply this approach in the real world, we may observe 
administrative lacks due to billing process in the insurance system, and then we may catch the 
disease information a few weeks later than current surveillance system. Therefore, a new real-
time technical structure such as real-time ‘drug utilized review (DUR)’ service in South Korea 
and monitoring and evaluation need to be considered as a set of surveillance system when the 
new surveillance approach is introduced.  
Lastly, the use of other timeliness comparison methods needs to be considered. In this 
study, we applied three different approaches and used two of them to make a conclusion of the 
timeliness of a new data source. There were three different metrics in terms of influenza 
activity monitoring over time; average epidemic curve, seasonal threshold, alert threshold. 
Those two methods used to make a conclusion are based on only average epidemiological 
curve perspectives. Since there were two more perspectives in influenza activity motioning, 
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Figure 3-1. Proportion of influenza-like-illness and weekly incidence of influenza out-patient, pneumonia and influenza 
in-patient, and severe acute respiratory illness with base case definitions in South Korea during influenza season 2010 to 
2012   
 
Figure 3-2. Proportion of influenza-like-illness and weekly incidence of influenza out-patient, pneumonia and influenza 
in-patient, and severe acute respiratory illness with extended case definitions in South Korea during influenza season 2010 to 




Table 3-1. Peak week of influenza-like-illness and influenza out-patient, pneumonia and influenza in-patient, and severe 
acute respiratory illness in South Korea during influenza season 2010 to 2012   
 PEAK WEEK by EPIWEEK 
 Reference FLUOPD PNIADM SARI eFLUOPD ePNIADM eSARI 
10 2010w52 2010w52 2011w1 2011w1 2010w52 2011w1 2011w1 
11 2012w6 2012w7 2012w8 2012w8 2012w7 2012w5 2012w5 
12 2013w9 2013w8 2013w9 2013w9 2013w8 2013w9 2013w9 
 
Table 3-2. Peak week difference between proportion of influenza-like-illness and weekly incidence of influenza out-
patient, pneumonia and influenza in-patient, and severe acute respiratory illness in South Korea during influenza season 
2010 to 2012   
 PEAK WEEK DIFFENCE 
 
Reference FLUOPD PNIADM SARI eFLUOPD ePNIADM eSARI 
10 
 
0 1 1 0 1 1 
11 
 
1 2 2 1 -1 -1 
12 
 
-1 0 0 -1 0 0 
Mean  0.00 1.00 1.00 0.00 0.00 0.00 
 
Table 3-3. The maximum cross-correlation value between proportion of influenza-like-illness and weekly incidence of 
influenza out-patient, pneumonia and influenza in-patient, and severe acute respiratory illness in South Korea during 
influenza season 2010 to 2012. 
 The MAXIMUM CROSS-CORRELATION VALUE 
 
Reference FLUOPD PNIADM SARI eFLUOPD ePNIADM eSARI 
10 
 
0.958 0.676 0.729 0.957 0.666 0.715 
11 
 
0.982 0.768 0.766 0.985 0.797 0.817 
12 
 
0.982 0.801 0.770 0.986 0.782 0.743 
Mean  0.974 0.748 0.755 0.976 0.748 0.758 
 
Table 3-4. The time lag in maximum cross-correlation value between proportion of influenza-like-illness and weekly 
incidence of influenza out-patient, pneumonia and influenza in-patient, and severe acute respiratory illness in South Korea 
during influenza season 2010 to 2012.  
 The TIME LAG in MAXIMUM CROSS-CORRELATION VALUE 
 
Reference FLUOPD PNIADM SARI eFLUOPD ePNIADM eSARI 
10 
 
-1 -1 -1 -1 0 0 
11 
 
0 1 0 0 1 1 
12 
 
0 2 1 0 1 1 








Table 3-5. The first week of aberration signals by The Early Aberration Reporting System (EARS) with high sensitivity 
setting from influenza-like-illness and influenza out-patient, pneumonia and influenza in-patient, and severe acute 
respiratory illness in South Korea during influenza season 2010 to 2012. 
 The FIRST WEEK of ABERRATION SIGNAL with HIGH SENSITIVITY 
 
Reference FLUOPD PNIADM SARI eFLUOPD ePNIADM eSARI 
10 2010w37 2010w39 2010w40 2010w40 2010w38 2010w40 2010w41 
11 2011w36 2011w38 2011w36 2011w36 2011w36 2011w36 2011w36 
12 2012w38 2012w38 2012w37 2012w42 2012w37 2012w44 2012w44 
 
Table 3-6. The time difference on first week of aberration signals by The Early Aberration Reporting System (EARS) with 
high sensitivity setting from influenza-like-illness and influenza out-patient, pneumonia and influenza in-patient, and severe 
acute respiratory illness in South Korea during influenza season 2010 to 2012. 
 The TIME DIFFERENT of FIRST WEEK of ABERRATION SIGNAL with HIGH SENSITIVITY 
 
Reference FLUOPD PNIADM SARI eFLUOPD ePNIADM eSARI 
10 
 
2 3 3 1 3 4 
11 
 
2 0 0 0 0 0 
12 
 
0 -1 4 -1 6 6 
Mean  1.33 0.67 2.33 0.00 3.00 3.33 
 
Table 3-7. The first week of aberration signals by the Early Aberration Reporting System (EARS) with high specificity 
setting from influenza-like-illness and influenza out-patient, pneumonia and influenza in-patient, and severe acute 
respiratory illness in South Korea during influenza season 2010 to 2012. 
 The FIRST WEEK of ABERRATION SIGNAL with HIGH SPECIFICITY 
 
Reference FLUOPD PNIADM SARI eFLUOPD ePNIADM eSARI 
10 2010w50 2010w49 n/a n/a 2010w49 n/a n/a 
11 2012w1 2012w1 n/a n/a 2012w1 n/a n/a 
12 2013w1 2013w1 n/a n/a 2013w1 n/a n/a 
 
Table 3-8. The time difference on first week of aberration signals by the Early Aberration Reporting System (EARS) with 
high specificity setting from influenza-like-illness and influenza out-patient, pneumonia and influenza in-patient, and severe 
acute respiratory illness in South Korea during influenza season 2010 to 2012. 
 The TIME DIFFERENT of FIRST WEEK of ABERRATION SIGNAL with HIGH SPECIFICITY 
 
Reference FLUOPD PNIADM SARI eFLUOPD ePNIADM eSARI 
10 
 
-1 n/a n/a -1 n/a n/a 
11 
 
0 n/a n/a 0 n/a n/a 
12 
 
0 n/a n/a 0 n/a n/a 





Figure 3-3. Application of the Early Aberration Reporting System (EARS) with high sensitivity/high specificity setting to 
reference and proposed surveillance source with different case definitions.  
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Chapter 4 : The comparison of seasonal influenza trends in South 
Korea 2010-2013: temporal association of influenza activity by different 





Objective To evaluate the temporal association of seasonal influenza activity by different 
geographical subdivisions and age groups in South Korea 2010-2013. 
Participants Randomly sampled residents, 1,021,576 who lived in South Korea from 36th weeks 
2010 to 35th weeks of 2013. 
Methods Influenza case was defined by influenza-related diagnosis in the national insurance billing 
information. We applied 3 different timeliness validation methods (peak time comparison, aberration 
time comparison, and time-series correlation) to 16 different subdivisions and 5 different age groups to 
national observation and measured time difference. 
Results For a peak time comparison, time difference by geographical subdivision ranged from -4 
weeks to 7 weeks and by age group ranged from -2 to 6 weeks. For time-series correlation, time lag 
ranged from -1 to 3 weeks in geographical comparison and was -1 week to 1 week in age group 
comparison. For aberration time comparison with high specificity model, time difference of the first 
aberration signal was from 0 to 7 weeks in geographical subdivision and was -12 weeks to 3 weeks in age 
group analysis.  
Conclusions Seoul Capital Area showed an earlier sign of influenza activity by peak time and 
correlation. Age between 6 to 15 showed a prior peak and time lag to national observation after 
accounting double peak phenomenon and age over 65 showed the later sign of influenza. Public health 
professionals and subdivision governments should focus those subpopulations for an early sign of 




Influenza is one of the most common infectious diseases in the world and has the largest burden of 
disease in mortality and morbidity1,2. Influenza virus has distinctive patterns of transmission with 
symptom development by temperature and humidity in the temperate region3,4. It is commonly known 
as ‘seasonal’ influenza due to its annual activity pattern in temperate climate region5. Even though it 
usually develops its seasonal activity at the beginning of the winter on each hemisphere, the exact time 
of aberration is different year by year and by distinct sub-population6. 
There have been many studies to monitor temporal trends of influenza by region and age group. 
Traditionally it is known that influenza showed different activity by region, altitude, and climate4. 
Researchers in the United States identified that influenza aberration at school children in Washington 
DC preceded the sign of influenza activity compare to the sentinel sites in Atlanta7. Recent studies on 
influenza confirmed cases in Mexico identified that influenza outpatient peak differed by state level and 
influenza activity from some states could be a predictor for the national-level influenza outbreak 
activity8,9. 
However, there is no study conducted in South Korea to understand the influenza temporal trends 
by different geographical subdivision or different age group. South Korea once had an influenza 
surveillance system with stratified influenza-like-illness proportion reporting by 4 different regions, but 
no temporal association investigation was conducted10. After revision of sentinel surveillance, Korea 
Centers for Disease Control and Preventions started providing the influenza-like-illness proportion by 
different age group in their public reports, but no information on temporal association between age 
group was presented11. Moreover, due to the small sample size and lack of the representativeness from 
the sentinel sites, the current surveillance system cannot provide influenza activity by political 
subdivision level, which is the second largest unit of policy implementation after national level12.  
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Importantly, the influenza-like-illness proportion cannot present exact disease temporal trends due to 
the large proportion of chronic disease in the denominator, especially in the elderly age group.  
 
Monitoring temporal trends of influenza and its related disease by different sub-population is 
beneficial to decrease the transmission in population and establish a set of public health preparedness. 
By identifying the first group who showed the aberration of influenza activity, we could set up 
vaccination strategy to reduce the starts at the population or will could target that population for early 
initiation of treatment to reduce transmission of influenza at the beginning of the season13–16. Through 
understanding temporal associations between communities and disease intensity, we could use those 
serial patterns in population as a tool of early aberration alert system. Moreover, assessing the disease 
dynamics by disease intensity, we could prepare the peak of severe cases which help us to establish 
public health preparedness. 
Therefore, we propose a study to compare temporal trends of influenza by geographical subdivision 
and age group. This approach will help us to capture the difference of seasonal influenza activity by each 
state or provinces and age group and also understand the temporal association between those 
subpopulations. Importantly, identifying subpopulation who start the influenza activity first will guide us 
to set up public health preparedness by considering those subpopulations as an early signal from 
national-wide influenza activity.  
Method 
The study population was defined individuals who lived in South Korea from the 36th week of 2010 
to 35th week of 2013 (which is corresponded influenza surveillance year from 2010 to 2012) from the 
National Health Insurance Service-National Same Cohort17. We used the national health insurance data 
sharing program to assess the data. The National Sample Cohort provides nationally representative 
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individuals with stratified random sampling process based on age, sex, eligibility of the insurance and 
income level18.  
We used one of the commonly used case definitions to determine influenza activity in the 
surveillance by other researchers19,20. Influenza activity is considered any influenza-specific diagnostic 
code (J09-J11) in primary diagnosis code in billing information without a repeated visit in 30 days at 
primary outpatient health care facilities only. Based on this case definition, we calculated the number of 
cases by epidemiological week with geographical subdivisions and age-group. We used the mid-year 
population by each surveillance year as the population at risk. The number of individuals by each 
population on the last day of the year used as a denominator to calculate the weekly incidence of 
influenza.  
We followed timeliness validation approaches to quantify temporal associations21–28. We applied 
three different methods to present time difference; peak time comparison, cross-correlation, and 
aberration time comparison. For peak time comparison, we calculated the week of the highest number 
in influenza activity and compared the time of between two groups. In cross-correlation, we 
transformed observations into time series format and calculated the correlation values with different 
time lags. We counted the time lag with maximum correlation value as the time difference. At the 
aberration time comparison, we adopted the early aberration reporting system (EARS) developed by the 
United States Centers for Disease Control and Preventions29,30. We modified EARS’s signal algorithms to 
adjust the sensitivity and specificity of the model. We defined the first signal from the C3 algorithm as 
an aberration signal in high sensitivity setting to focus on generating signals from any suspicious activity. 
In contrast, we defined the two consecutive signals from C1 algorithm as an aberration signal in high 
specificity setting to reduce the false positive from the signals based on non-seasonal influenza activity. 
Finally, we tabulated the first week of aberration signals from each population and calculated the time 
difference by two different sensitivity setting. 
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To describe the temporal association of seasonal influenza activity, we stratified our comparison in 
two different strata, geographical subdivision and age group. We applied the ISO 3166-2 published by 
the international organization for standardization into geographic location to make 16 different 
subdivisions, which is commonly known as state-level or province-level31. However, we had to exclude 
Se-Jong Special Self-governing City due to rapid population changes since it was newly established 
during the study period32. We followed the Global Epidemiological Surveillance Standards for Influenza 
by the World Health Organization to process age-grouping33. Due to the confidentiality of individuals in 
the data sharing program, we could not calculate the exact age at the time medical visit. Therefore, we 
used the middle-year age during the surveillance year as a reference and merged two youngest age 
group 0-2 year and 2-5 year as one group age under 5. At last, we used 5 different major age grouping 
for analysis: age under 5 years, 5 to 15 years, 15 to 50 years, 50 to 65 years, and over 65 years. 
Results 
At the national level, the peak week of influenza activity was the 52nd week of 2010, 7th week of 
2012, and 8th week of 2013 for 2010, 2011 and 2012 influenza season. In state-level comparison, the 
peak week of influenza ranged from 51st week of 2010 to 2nd week of 2011, from 6th of 2011 to 13th 
week of 2012, and from 4th week of 2012 to 11th week of 2013 respectively. (Table 4-1 and Figure 4-1) 
The time difference of geographical subdivision level compared to the national level by peak level 
comparison ranged from 4 weeks early (-4 week, Seoul and Jeju 2012 season) to 6 weeks late (+6 week, 
Daejeon 2011 season). For three years average, Seoul showed two weeks of early peak week while 
ChungBuk showed 2 weeks of later peak compared to the national peak. (Table 4-2) 
For cross-correlation value comparison in geographical subdivision comparison, the maximum cross-
correlation value ranged from 0.750 (Daejeon season 2011) to 0.990 (GyeonNam season 2010). For 
three years average, Busan showed the highest value as 0.979, and Jeju showed the lowest value as 
0.780. (Table 4-3) 
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For the time difference measured by time lag with maximum cross-correlation value were one week 
early (-1 week) to 3 weeks late (+3 week). Three years average time lag was -0.33 week from Seoul and 
Gangwon, and 1 week late for JeonBuk. (Table 4-4) 
The first week of aberration signal from high sensitivity model was 39th week of 2010, 38th week of 
2011 and 38th week of 2012 at national level, and from 36th week to 50th week for 2010 season, 37th 
week to next year’s 1st week for season 2011 and 36th week to 50th week for season 2010. The time 
difference of the first week of aberration signal from high sensitivity model was -3 weeks (Seoul 2010 
season) early to 15 weeks late (Ulsan 2011 season). For three years average, ChungNam showed the 
least late time difference as 0.67 week while Ulsan showed the most time difference by 11 weeks of 
later signals. In 2012 season, we could not detect the aberration signal from Jeju based on high 
sensitivity model definition. (Table 4-5 and 4-6). 
The 49th week of 2010, 1st week of 2012 and 2013 were the first week of aberration signal from 
high specificity model. The range of the first week by geographical subdivision was from 50th week to 
52nd week of 2010, 2nd week to 5th week of 2012, and 2nd week of 2012 to 8th week of 2013 for 2010, 
2011 and 2012 season. In subdivision level time different comparison, Daejeon showed the least time 
difference compared to the national level, Jeju showed the most time difference as 4-week later signal. 
However, we could not detect 14 aberration signals based on the high specificity model case definition. 
(Table 4-7 and 4-8).  
In age group temporal association analysis, the peak week of influenza activity by age group was 
51st week of 2010 to 1st week of 2011 for 2010 season, 5th week to 13th week of 2012 for 2011 season, 
and 7th week to 8th week of 2013 for 2012 season. The time difference by peak time comparison was -2 
weeks (Age under 5 in season 2011) to 6 weeks (Age 6-15 in season 2011). For three average, Age under 
5 showed the earlier peak (- 0.67 week), and Age 6-15 showed 1.67 week later peak compared to the 
overall national peak. (Table 9, 10 and Figure 4-2)  
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The maximum cross-correlation value ranged from 0.859 (Age over 65 in 2011 season) to 0.998 (Age 
16-50 in 2010 season) for 3 years. The 3 years average maximum cross-correlation value by age group 
was 0.897 (Age over 65) to 0.986 (Age 16-50).  The time difference measured by the time lag with 
maximum cross-correlation value was -1 week to 1 week, and -0.33 week early in Age 6-15 group and 
0.67 week late in Age-under-5 group in 3 years average. (Table 4-11 and 4-12)  
The first week of aberration signals with high sensitivity model was the 36th week to 41st week for 
2010 season, 36th week to 52nd week for 2011 season, and 38th week to next year’s 2nd week for 2012 
season. The time difference from each age group compared to the overall national signal were 3 weeks 
early (-3 weeks, Age 51-65 in 2010 season) to 16 weeks late (+16 weeks, Age over 65 in 2012 season). In 
three years average, Age 6-15 showed the -1 week earliest signal but Age under 5 showed 6 weeks last 
signal compared to the reference. (Table 4-13, 4-14, and Figure 4-3)  
In high specificity setting model, the first week of aberration signal was 37th week to 52nd week in 
2010 season, 2nd week to 3rd week of next year’s in 2011 season, and 3rd to 4th week of the following 
year’s in 2012 season. The time difference was -12 weeks earlier (Age 6-15 in 2010 season) to 3 weeks 
later (Age 51-65 in 2010 season and Age 6-15 in 2012 season). In 3 year-average, Age under showed -
2.33 week of early signal and Ager 51-65 showed 2.5 weeks of the late signal. However, in the high 
specificity model, we could not generate the eligible signals based on case definition in Age over 65, and 
Age 51 – 65 at the year of 2012 (Table 4-15 and 4-16)  
Discussion 
There were early peaks in the area of Seoul Capital Area; Seoul, Gyeonggi, and Incheon. Those 
subdivision areas are located in the north-west of South Korea and highly populated area. There are two 
potential causes of this phenomenon. A recent study from the Science mentioned that the large 
population needs to be considered as an epicenter of influenza activity34,35. Since the Seoul Capital Area 
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contributes 50% of the entire population, we may think the Seoul Capital Area is an epicenter for South 
Korea. 
Moreover, previous studies in other countries suggested that the seasonality of influenza patterns is 
more like depends on the transmission of specific strains from the tropical region36,37. South Korea does 
not have any land border, the most common way come in and out of the country is through the air flight 
or major port. Incheon, connected Seoul with land boarder, has the largest airport in South Korea and 
major harbor ports connected with China. The origin of influenza activity can be imported from 
international travelers entering South Korea through Seoul Capital Area.  
There are some odd delays of influenza peak in season 2011. Those observations are due to double 
peak patterns in influenza activity12,38. Not like 2010 and 2012, season 2011 showed the double peak 
pattern. In double-peak season, the first peak is usually the more prominent peak than the second peak. 
However, some geographical locations develop more prominent peaks in their second wave. The time 
difference in 2011 is due to the double-peak phenomenon, not time difference.  
Seoul, Gyeonggi-do, and Busan showed the highest value in 3 years average at the maximum cross-
correlation comparison. It is more like the population contribution from those subdivisions to the nation 
is large enough to show the strong cross-correlation. At the same time, Jeju showed 75% of cross-
correlation value which is the lowest in the states.  The reason why Jeju showed different pattern could 
be considered that because Jeju is an island apart from mainland South Korea. However, Jeju is the 
smallest subdivision unit among 16 states. Moreover, due to the small participants after stratified 
sampling process, we frequently observed 0 cases per week in Jeju. Therefore, it is not clear Jeju island 
has unique patterns of influenza activity, or it is due to lack of the observation in time series analysis, we 
need to give extra caution on interpreting the cross-correlation values, especially when we have 
different population contribution to the nation from each subdivision. 
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Even though we could not make any definite conclusion about the temporal association in age group 
comparison, there are two directions about the temporal association. Age under 5 and 6 to 15 showed 
the early development of influenza activity, and age over 65 showed little delayed activity of influenza 
compared to the overall population.  
Age over 65 showed late development of influenza in peak time and cross-correlation comparison. 
There are two potential explanations for this. First, this can be due to actual disease transmission 
dynamic; we have the first transmission in young people, then later transmission in older people23. A 
second potential explanation is about access to health. Compared to younger people, older people did 
not recognize their symptom until it developed as severe cases35. So, they came to the clinic a few days 
(or a week) later compare to the younger people even though they have the same time of infected. We 
need more studies to understand the phenomenon whether later influenza activity in older people is 
due to actual disease dynamics or social factors related to access to health. 
Age 6-15 showed early sings in aberration time comparison. Those signals in high sensitivity setting 
at the age group 5-15 are due to in school openings in September39,40. Even though in timeliness 
comparison approach, we consider these signals as false positive for influenza high activity, these signals 
are important as situation awareness for the potential beginning point of influenza outbreak and can be 
used a key for pandemic preparedness  
This study has strength with implication point. This approach showed the possibility of use of billing 
information in stratified influenza surveillance, especially in temporal trends monitoring. Current 
influenza surveillance used sentinel surveillance with influenza-like-illness with little or no stratification 
on a specific population. In this study, we used billing information as surveillance source and stratified 
influenza activity by different geographical subdivision and age group as world health organization 
suggested. Moreover, the current health insurance system with real-time Drug Utilization Review (DUR) 
gives direction to establish real-time influenza surveillance based on billing information shortly.  
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Moreover, based on this analysis, we could specify a potential target population to monitor 
influenza activity. Even though we did not have enough observation years to build a particular direction 
of the temporal association between subpopulation, there is a trend of influenza activity by different 
geographical location and different age group. With more years of observation to support this direction, 
we could find a key location or/and age group as a beginning point of influenza activity in South Korea. 
Enhancing vaccination strategy, early massive initiation of treatment, and campaigns to reduce the 
transmission in hospital and community in key population will be an essential public health 
preparedness plan to reduce the burden and intensity of influenza in the future. 
However, there are a few limitations when we need to consider the use of this study. First, we only 
have 3 years of observation in this study. Some of the findings showed the clear direction of the 
temporal association; most of the observations did not show the clear direction of association in the 
limited study period. We need to include more years in a future study to find out concordance patterns 
of association in long term observation.  
 
Second, national level observation is probably not sufficiently independent from subpopulation 
observations. We used one of the most common ways to validate the timeliness of two different data 
source. However, in aim 3, our data comparison was conducted by geographical subdivision level or age-
group to the national average which made of those subpopulations. For example, Seoul Capital Area 
contributes 50% of the entire Korean population. Therefore, their maximum cross-correlation value 
should be high in comparison. The peak observed in Seoul Capital Area contributions 50% of peak in 
national peak due to population size. Therefore, comparing the temporal trends association to the 
nation observation may give us bias result. However, there is no clear standard or guideline to analyze 
the subpopulation level trends. More studies on methods development on temporal trends analysis are 
needed to provide precise estimation about those associations. 
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Finally, the use of aberration detection algorithm in temporal trends comparison gives more 
information on model validity rather than temporal associations by population. As it was discussed 
previous literature, aberration signals from influenza activity highly depend on a model setting with 
sensitivity and specificity or model selection process itself21,30. We have more and early signals in high 
sensitivity setting, but those can be easily considered as false positive. Sometimes we could not 
generate aberration signals based on our case definition in high specificity setting. If we used the other 
model, instead of EARS, we may see the same results based on model sensitivity and specificity. Most of 
the signal generating algorithms are based on previous years or weeks observation in that data source, 
which means there is no universal signal generating algorithms which can be applied easily in all 
different dataset. Therefore, it is appropriate to use aberration signals comparison as a supplementary 
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Table 4-1. Peak week of influenza out-patient in South Korea and other 16 different states during influenza season 2010 to 2012   
PEAK WEEK by EPIWEEK 
 Nation Seoul Busan Daegu Incheon Gwangju Daejeon Ulsan Jeju 
10 2010w52 2010w52 2010w52 2010w52 2010w51 2010w52 2010w52 2010w52 2010w51 
11 2012w7 2012w5 2012w7 2012w7 2012w13 2012w7 2012w14 2012w12 2012w7 
12 2013w8 2013w4 2013w8 2013w8 2013w5 2013w8 2013w5 2013w9 2013w4 
  Gyeongi Gangwon Chung-Buk Chung-Nam Jeon-Buk Jeon-Nam Gyeon-Buk Gyeon-Nam 
10  2010w52 2010w51 2011w2 2010w52 2011w1 2010w52 2010w51 2010w52 
11  2012w6 2012w7 2012w13 2012w13 2012w7 2012w8 2012w7 2012w7 
12  2013w7 2013w7 2013w9 2013w8 2013w11 2013w8 2013w7 2013w8 
 
 
Table 4-2. Peak week difference of influenza out-patient between South Korea and other 16 different states during influenza season 2010 to 2012   
PEAK WEEK DIFFENCE 
 Nation Seoul Busan Daegu Incheon Gwangju Daejeon Ulsan Jeju 
10  0 0 0 -1 0 0 0 -1 
11  -2 0 0 6 0 7 5 0 
12  -4 0 0 -3 0 -3 1 -4 
  Gyeongi Gangwon Chung-Buk Chung-Nam Jeon-Buk Jeon-Nam Gyeon-Buk Gyeon-Nam 
10  0 -1 2 0 1 0 -1 0 
11  -1 0 6 6 0 1 0 0 







Table 4-3. The maximum cross-correlation value of influenza out-patient in South Korea and other 16 different states during influenza season 2010 to 2012. 
The MAXIMUM CROSS-CORRELATION VALUE 
 Nation Seoul Busan Daegu Incheon Gwangju Daejeon Ulsan Jeju 
10  0.985 0.989 0.985 0.975 0.983 0.982 0.966 0.768 
11  0.987 0.975 0.927 0.938 0.895 0.750 0.936 0.835 
12  0.936 0.972 0.914 0.870 0.943 0.885 0.905 0.737 
  Gyeongi Gangwon Chung-Buk Chung-Nam Jeon-Buk Jeon-Nam Gyeon-Buk Gyeon-Nam 
10  0.998 0.914 0.862 0.961 0.879 0.962 0.981 0.990 
11  0.990 0.943 0.884 0.913 0.880 0.921 0.944 0.954 
12  0.956 0.830 0.918 0.938 0.772 0.938 0.945 0.956 
 
 
Table 4-4. The time lag in maximum cross-correlation value of influenza out-patient in South Korea and other 16 different states during influenza season 2010 to 2012. 
The TIME LAG in MAXIMUM CROSS-CORRELATION VALUE 
 Nation Seoul Busan Daegu Incheon Gwangju Daejeon Ulsan Jeju 
10  0 0 0 0 0 0 0 1 
11  0 0 0 0 0 0 0 0 
12  -1 0 0 0 0 0 0 -1 
  Gyeongi Gangwon Chung-Buk Chung-Nam Jeon-Buk Jeon-Nam Gyeon-Buk Gyeon-Nam 
10  0 -1 0 0 0 0 0 0 
11  0 0 0 0 0 0 0 0 







Table 4-5. The first week of aberration signals in influenza out-patient by the Early Aberration Reporting System (EARS) with high sensitivity setting in South Korea and 
other 16 different states during influenza season 2010 to 2012. 
The FIRST WEEK of ABERRATION SIGNAL with HIGH SENSTIVITY 
 Nation Seoul Busan Daegu Incheon Gwangju Daejeon Ulsan Jeju 
10 2010w39 2010w36 2010w44 2010w49 2010w39 2010w44 2010w41 2010w50 2010w39 
11 2011w38 2011w47 2011w49 2011w38 2011w46 2011w36 2011w52 2012w1 2011w44 
12 2012w38 2012w39 2012w46 2012w40 2012w38 2012w38 2012w41 2012w45  
  Gyeongi Gangwon Chung-Buk Chung-Nam Jeon-Buk Jeon-Nam Gyeon-Buk Gyeon-Nam 
10  2010w39 2010w41 2010w39 2010w39 2010w50 2010w47 2010w42 2010w44 
11  2011w42 2011w37 2011w52 2011w39 2011w41 2011w40 2011w51 2011w41 
12  2012w40 2012w50 2012w37 2012w39 2012w36 2012w41 2012w41 2012w50 
 
 
Table 4-6. The time difference on first week of aberration signals in influenza out-patient by the Early Aberration Reporting System (EARS) with high sensitivity setting in 
South Korea and other 16 different states during influenza season 2010 to 2012. 
The TIME DIFFERENT of FIRST WEEK of ABERRATION SIGNAL with HIGH SENSTIVITY 
 Nation Seoul Busan Daegu Incheon Gwangju Daejeon Ulsan Jeju 
10  -3 5 10 0 5 2 11 0 
11  9 11 0 8 -2 14 15 6 
12  1 8 2 0 0 3 7  
  Gyeongi Gangwon Chung-Buk Chung-Nam Jeon-Buk Jeon-Nam Gyeon-Buk Gyeon-Nam 
10  0 2 0 0 11 8 3 5 
11  4 -1 14 1 3 2 13 3 






Table 4-7. The first week of aberration signals in influenza out-patient by the Early Aberration Reporting System (EARS) with high specificity setting in South Korea and 
other 16 different states during influenza season 2010 to 2012. 
The FIRST WEEK of ABERRATION SIGNAL with HIGH SPECIFICITY 
 Nation Seoul Busan Daegu Incheon Gwangju Daejeon Ulsan Jeju 
10 2010w49 2010w50 2010w52 2010w50 2010w51 2010w51 2010w51 2010w51  
11 2012w1 2012w3 2012w1 2012w2 2012w4 2012w3 2012w1 2012w3 2012w5 
12 2013w1  2013w3 2013w8 2013w1 2013w4    
  Gyeongi Gangwon Chung-Buk Chung-Nam Jeon-Buk Jeon-Nam Gyeon-Buk Gyeon-Nam 
10  2010w51 2010w51  2010w51  2010w52 2010w51 2010w51 
11  2012w1 2012w4  2012w3 2012w4 2012w3 2012w3 2012w3 
12  2013w2      2013w3  
 
 
Table 4-8. The time difference on first week of aberration signals in influenza out-patient by the Early Aberration Reporting System (EARS) with high specificity setting in 
South Korea and other 16 different states during influenza season 2010 to 2012. 
The FIRST WEEK of ABERRATION SIGNAL with HIGH SPECIFICITY 
 Nation Seoul Busan Daegu Incheon Gwangju Daejeon Ulsan Jeju 
10  1 3 1 2 2 2 2  
11  2 0 1 3 2 0 2 4 
12   2 7 0 3    
  Gyeongi Gangwon Chung-Buk Chung-Nam Jeon-Buk Jeon-Nam Gyeon-Buk Gyeon-Nam 
10  2 2  2  3 2 2 
11  0 3  2 3 2 2 2 











Table 4-9. Peak week of influenza out-patient in South Korea and 5 different age group during influenza season 2010 to 
2012   
 PEAK WEEK by EPIWEEK 
 Reference Age under 5 Age 6-15 Age 16-50 Age 51-65 Age over 65 
10 2010w52 2010w52 2010w51 2010w52 2010w52 2011w1 
11 2012w7 2012w5 2012w13 2012w7 2012w7 2012w8 
12 2013w8 2013w8 2013w8 2013w7 2013w8 2013w8 
 
 
Table 4-10. Peak week difference of influenza out-patient between South Korea and 5 different age group during 
influenza season 2010 to 2012   
 PEAK WEEK DIFFENCE 
 Reference Age under 5 Age 6-15 Age 16-50 Age 51-65 Age over 65 
10  0 -1 0 0 1 
11  -2 6 0 0 1 
12  0 0 -1 0 0 
 
 
Table 4-11. The maximum cross-correlation value of influenza out-patient in South Korea and 5 different age group 
during influenza season 2010 to 2012. 
 The MAXIMUM CROSS-CORRELATION VALUE 
 Reference Age under 5 Age 6-15 Age 16-50 Age 51-65 Age over 65 
10  0.955 0.942 0.998 0.958 0.876 
11  0.985 0.946 0.984 0.941 0.859 
12  0.964 0.948 0.976 0.956 0.955 
 
 
Table 4-12. The time lag in maximum cross-correlation value of influenza out-patient South Korea and 5 different age 
group during influenza season 2010 to 2012. 
 The TIME LAG in MAXIMUM CROSS-CORRELATION VALUE 
 Reference Age under 5 Age 6-15 Age 16-50 Age 51-65 Age over 65 
10  1 -1 0 1 1 
11  0 0 0 0 0 







Table 4-13. The first week of aberration signals in influenza out-patient by the Early Aberration Reporting System (EARS) 
with high sensitivity setting in South Korea and 5 different age group during influenza season 2010 to 2012. 
 The FIRST WEEK of ABERRATION SIGNAL with HIGH SENSITIVITY 
 Reference Age under 5 Age 6-15 Age 16-50 Age 51-65 Age over 65 
10 2010w39 2010w41 2010w37 2010w39 2010w36 2010w39 
11 2011w38 2011w52 2011w36 2011w36 2011w41 2011w37 
12 2012w38 2012w40 2012w39 2012w38 2012w38 2013w2 
 
Table 4-14. The time difference on first week of aberration signals in influenza out-patient by the Early Aberration 
Reporting System (EARS) with high sensitivity setting in South Korea and 5 different age group during influenza season 2010 
to 2012. 
 The TIME DIFFERENT of FIRST WEEK of ABERRATION SIGNAL with HIGH SENSITIVITY 
 Reference Age under 5 Age 6-15 Age 16-50 Age 51-65 Age over 65 
10  2 -2 0 -3 0 
11  14 -2 -2 3 -1 
12  2 1 0 0 16 
 
Table 4-15. The first week of aberration signals in influenza out-patient by the Early Aberration Reporting System (EARS) 
with high specificity setting in South Korea and 5 different age group during influenza season 2010 to 2012. 
 The FIRST WEEK of ABERRATION SIGNAL with HIGH SPECIFICITY 
 Reference Age under 5 Age 6-15 Age 16-50 Age 51-65 Age over 65 
10 2010w49 2010w50 2010w37 2010w51 2010w52   
11 2012w1 2012w3 2012w3 2012w2 2012w3   
12 2013w1 2013w3 2013w4 2013w3    
 
 
Table 4-16. The time difference on first week of aberration signals in influenza out-patient by the Early Aberration 
Reporting System (EARS) with high specificity setting in South Korea and 5 different age group during influenza season 2010 
to 2012. 
 The TIME DIFFERENT of FIRST WEEK of ABERRATION SIGNAL with HIGH SPECIFICITY 
 Reference Age under 5 Age 6-15 Age 16-50 Age 51-65 Age over 65 
10  1 -12 2 3  
11  2 2 1 2  






Figure 4-3. Application of the Early Aberration Reporting System (EARS) with high sensitivity/high specificity setting in 




Chapter 5 : Key findings, implications, and future directions 
Summary of findings  
We proposed the use of billing information as surveillance source in disease burden estimation and 
temporal trends monitoring. We were able to estimate the burden of influenza with different case 
definition and provided stratified disease burden as WHO guided. We did not see any delays of influenza 
out-patient activity drawn from billing information compared to the current sentinel surveillance. 
Moreover, we observed potential temporal associations of influenza activity by different subpopulation. 
Aberration time comparison was not sufficient to compare timeliness validation between two different 
sources neither investigate temporal associations between different subpopulation.  
Summary of aim 1 
In chapter 2 (aim1), we aimed to estimate the burden of influenza and its related disease based on 
billing information. We applied three different case definitions based on disease codes in primary and 
secondary diagnosis to calculate the annual disease burden, then stratified by geographical subdivisions 
and age-group. We found an unequal distribution of disease burden by geographical subdivisions and 
different disease burden by different age group. There was a pattern change of diagnosis of seasonal 
influenza out-patients especially age under 5 and over 65 by the time of 2009 pandemic influenza.  
The unequal distribution of influenza burden by geographical subdivision could be due to population 
crowding and early initiation of influenza treatment in an urban area. Different disease burden by 
different age group supported current government influenza vaccination system. Lastly, we showed the 
possibility of use of billing information in surveillance, especially disease burden estimation, and 
temporal trends monitoring.  
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Summary of aim 2 
In chapter 3 (aim 2), we validate the timeliness of epidemiological curves drawn from billing 
information compared to current sentinel surveillance as temporal trends monitoring. We estimated 
weekly incidences of influenza out-patients, pneumonia and influenza in-patients, and severe acute 
respiratory illness. We applied peak time, cross-correlation values, and aberration time comparison as a 
timeliness validation method. We did not observe any delays of influenza out-patients activity compared 
to current sentinel surveillance in peak time and cross-correlation value comparison. There was a week 
of delay in pneumonia and influenza in-patients and severe acute respiratory illness, but it was more 
likely due to the natural history of disease rather than actually delays in surveillance. We could not use 
aberration time comparison since aberration signals highly depended on model sensitivity and specificity 
and model selection process itself.  
Summary of aim 3 
In chapter 4 (aim 3), we were able to perform influenza out-patient temporal trends association 
analysis by subpopulations. We applied timeliness validation methods to quantify differences of 
influenza activity by different geographical subdivision and age group. The Seoul Capital Area showed 
the early signs of influenza activity in peak and cross-correlation time comparison. Age 6 to 15 showed 
the early sign of influenza activity while age over 65 showed the later sing of influenza activity. As we 
addressed in chapter 3, the aberration time comparison was not ideal to quantify the time difference. 
The aberration signals were highly sensitive by model setting and model itself rather than 





Public Health Implications  
Use of billing information as surveillance source 
Traditionally influenza surveillance systems are based on selective sentinels to aggregate the 
information from the population or participated laboratory to see more specific information on 
subtypes and positive rate from the specimens1. There has been the use of billing information as 
surveillance source2, but those approaches could not fully apply to general influenza surveillance since 
there were limitations to define the population at risk in the study or community. However, in this 
study, we could apply billing information as a direct measure of disease burden and temporal trends 
monitoring since South Korea established a national wide, mandatory, universal, single-payer electric 
insurance system.  
Use of billing information could provide direct influenza burden by medical seeking behavior. 
Current influenza surveillance system and disease burden estimations in South Korea applied a complex 
statistical model to estimate the burden of influenza through sentinels or selective tertiary hospitals3,4. 
Even though they calculated the disease burden, those were still estimations from models, not direct 
measure. By applying peer-reviewed relevant case definitions of seasonal influenza, we were able to 
calculate the number of medical visits due to influenza illness and could provide the absolute number of 
influenza-related medical seeking behavior without a complex statistical model  
Use of billing information with representative sampling can provide a direct measure of influenza 
intensity instead of relative disease intensity drawn from proportion influenza-like-illness. One of the 
limitations of current influenza surveillance is a relative measure of disease intensity. For example, a 
recent influenza report stated that age over 65 showed the lowest proportion influenza-like-illness 
among all age group5. However, based on our analysis in annual incidence and weekly epidemiological 
curve figures, that is not true. Because age over 65 has a high number of medical visits due to their 
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chronic conditions which increased the number in the denominator in proportion calculation. With 
universal coverage of health insurance system and stratified sampling process from the entire 
population, we could easily define a population at risk and did provide weekly incidence of influenza, 
direct measure of disease.  
Use of billing information with representative sampling and a large number of participants could be 
used stratified surveillance by geographical subdivisions and age group. After revision of influenza 
surveillance 2013, current surveillance system used 200 sentinels, 100 for adult (70 internal medicine, 
30 family medicine), 100 for pediatrics3. However, those are not representative sentinels from each 
geographical subdivision (such as state/province or city/country) and 200 sentinels were not enough to 
provide sufficient information by geographical subdivision and age group surveillance information. The 
proposed approach in this dissertation used a million of individuals every year to estimate the disease 
burden and monitor temporal trends of seasonal influenza. Therefore, we could provide the influenza 
disease burden by different subpopulation, monitor temporal trends by subpopulation, and investigate 
the temporal association of influenza activity by subpopulation. 
Stratified surveillance 
Stratified disease burden estimation can be used in a revising vaccine strategy, medical resource 
allocation and identifying epidemiology of influenza.  Current influenza burden estimation could not 
provide stratified disease burden estimation based on geographical subdivision and different age group. 
Therefore, general assumptions for vaccine strategy and medical resource allocation were equal 
distribution of disease. However, with stratified disease burden estimation, there is a chance to identify 
high disease burden subpopulation based on geographical region and age group. Public health 
practitioners would revise vaccine strategy and medical resource allocation. Moreover, stratified disease 
burden estimation could provide more information on the epidemiology of influenza. Until recent years, 
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population size was considered as a driven factor for influenza transmission. However, based on recent 
publication with more specified information in influenza activity6, we know that population size is more 
act like modulator than a driven factor for transmission. Stratified disease burden estimation can be a 
base-data structure to investigate more about the epidemiology of influenza.    
Finding temporal trends association in influenza activity could be a key to reducing the transmission 
of influenza by understanding the disease dynamics of influenza. It was almost impossible to get entire 
populations disease behavior and knowledge about disease dynamics. In this dissertation, we were able 
to estimate the weekly incidence of influenza by geographical subdivision and age group with different 
case definitions. Based on those stratified temporal trends monitoring, we found out the possible 
temporal association of influenza activity by geographical subdivision and age group. Those 
subpopulations with early influenza activity could be a key population to prevent and control influenza 
activity. Providing intensive vaccination and providing early initiation of influenza treatment may reduce 
early influenza transmission in those population, which may reduce the entire population’s influenza 
activity. 
Future directions 
We need to add more recent years of observation to make a clear direction of temporal 
associations. In the begging of the study, we aimed to analysis 7 years of observation. However, there 
was a change of influenza diagnosis patterns by the time of the pandemic outbreak, we only used 3 
years of observation to analysis the temporal association of influenza. 3 years of observation is not 
enough to provide clear direction to establish policy development and revising strategy. Adding more 
observations with recent findings need to be done provide clear directions of temporal association.  
We need to implement a new approach in the surveillance system and monitor and evaluate the 
results. There has been a lot of new approaches and published papers in public health surveillance, but 
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most of them did not actually implement to the public health practice until now 7or even when they are 
implemented, it is hard to see any post monitoring and evaluations on those new approaches8. After 
other studies with extending observation, implementing this approach as another pillar of the influenza 
surveillance system needs to be prioritized. Moreover, providing monitoring and evaluation system 
need to be accompanied when this approach is actually applied.  
Final conclusion  
In this dissertation, we were able to estimate the burden of influenza more directly. Influenza out-
patient activity drawn from billing information did not show any delays in timeliness compared to the 
current influenza sentinel surveillance. Lastly, there was potential temporal trends association by 
geographical subdivision and age group.  
A surveillance system based on solely billing information never be perfect. Instead, other 
surveillance structures with surveillance with information can be a more stable surveillance system. The 
surveillance system should have different structures with the different data source to make 
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